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ABSTRACT 
 
Gene therapy is a promising new tool to treat some diseases that currently are incurable such as, genetic 
disorders, cancer diseases and some retinal diseases, but it has still not become an established practice in medicine 
mainly because of either insufficient efficacy or safety problems. The basic idea in gene therapy is straightforward: 
the failure to produce some protein coded by a defective gene is overcome by delivering a new intact gene into the 
nucleus of the cells. Since naked DNA as such is not usually efficiently internalized by cells, a carrier system is 
needed for gene delivery.  The first systems were based on modified viruses. However, the safety issues of viral 
gene delivery systems generated a new research field, non-viral gene delivery systems. A battery of different kinds 
of alternatives has been generated but none have achieved ultimate success: non-viral gene delivery systems are 
still less effective than viral systems.  
The objective of the present study was to develop new kinds of gene carriers and to study their suitability for 
gene delivery purposes, and also to study cellular mechanisms/properties involved in gene delivery. Systematic 
physicochemical and biological characterization of plasmid DNA (pDNA) carriers and mechanistic studies can 
help in designing new more efficient non-viral carriers. We investigated the role of structural properties (shape, 
PEGylation, molecular weight (MW)) of poly-L-lysine (PLL) gene carriers, and the influence of biological 
processes and properties (cell cycle, intracellular kinetics, glycosaminoglycans, (GAGs)) on polymeric DNA 
delivery into a cultured human retinal pigment epithelium (hRPE) cell line, D407. This is important cell line, since 
RPE maintains the function of photoreceptors and eyesight, and therefore, is a potential target for gene delivery. 
Physicochemical and biological structure-property relationships of PLLs (3–20 kDa) exhibited no clear correlations 
between the tested physicochemical properties (condensation, relaxation, zeta-potential, size and shape of the 
polyplexes) and biological activities (cell uptake, transgene expression and cytotoxicity of the polyplexes). Most 
PLLs (20 kDa) condense DNA (linear, grafted, branched > dendritic) and condensation is not decreased if the 
polyethylene glycol (PEG) content is about 60 % or less (fraction of MW). PEGylated PLLs (20 kDa) form 
sterically stabilized toroidal or rod-like complexes with diameters of 27–123 nm, but they are not totally protected 
from interacting with polyanionic chondroitin sulphate. Further studies with two carriers with different gene 
delivery properties, PLL 200 kDa and PEI 25 kDa (polyethyleneimine), demonstrated a relationship between cell 
cycle phase (G1, S, G2, M) and transfection efficiency. The transgene expression of the polyplexes is influenced 
by cellular uptake and transcription, and both processes are cell cycle-dependent. Cellular uptake of the polyplexes 
was at its highest during the S phase (80–90 %) and lowest during the G1 phase (5–30 %). PEI 25 kDa was a more 
efficient as a transfection agent than PLL 200 kDa. Furthermore, all promoters (CMV, SV40, tk, PDE-β) and 
reporter genes (β-galactosidase, luciferase) showed dependence on the cell cycle. However, as expected, only a 
small fraction of the pDNA was found in the nucleus, partly carrier-bound, but having been accumulated in a cell 
cycle-dependent manner. Interestingly, the gene expression after PEI25 kDa mediated transfection was 1–2 orders 
of magnitude higher than after PLL mediated delivery even though the gene transfer into the nuclei was 
approximately the same. This indicates that there is higher transcriptional efficacy after PEI transfection. Finally, 
since it is possible that interactions with endogenous polyanionic GAGs could interfere with cellular uptake or 
transgene expression, the GAG profile of synchronized D407 cells was determined. However, we found that the 
GAG contents alone do not explain the transfection efficiencies, since major changes occur simultaneously in the 
general rate of fluid-phase endocytosis, and nuclear access of the endocytosed pDNAs.  
In conclusion, the present study indicates that the physicochemical properties of PLL polyplexes can differ to 
some extent without this having any great impact on biological activity. Also, a knowledge of cell cycle-dependent 
variation in gene transfer can hep promote targeting in gene therapy into uncontrollably dividing cells in diseases 
such as proliferative vitreoretinopathy (PVR) and retinal generations, or different types of cancer diseases. 
Nonetheless even greater understanding of the intracellular kinetics of polyplexes and underlying molecular 
mechanisms of the diseases is needed before of non-viral gene therapy can become a clinical reality.  
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ABBREVIATIONS 
 
bp  base pairs 
CHEMS cholesteryl hemisuccinate, 3β-hydroxy-5-cholestene 3-hemisuccinate  
CMV  cytomegalovirus 
CPP  cell-permeable peptide 
CS  chondroitin sulfate 
D407 6-2 stably luciferase expressing retinal pigment epithelial cell line   
DEAE  diethylaminoethyl/diethylaminoether 
DNA  deoxyribonucleic acid 
DO  diolein, glycerol-1,2-and-1,3-dioleate 
DOGS  dioctadecylamidoglycylspermine 
DOPE  1,2-dioleyl-3-phosphatidylethanolamine 
DOTAP N-[1-(2,3-Dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsulfate  
DOTMA dioleyloxypropyl trimethylammonium bromide 
DPPES dipalmitoyl phosphatidylethanolamidospermine 
DTAF  5-(4,6-dichlorotriazinyl)aminofluorescein 
EDTA  ethylene diaminetetra acetic acid 
EMA  ethidium monoazide 
EtBr  ethidium bromide 
FITC  fluorescein isothiocyanate 
G1 phase Gap 1 phase of cell cycle 
G2 phase Gap 2 phase of cell cycle 
GAG  glycosaminoglycan 
HA  hyaluronic acid, hyaluronan 
HEPES 4-(2-hydroxyethyl)-1 piperazine ethane sulphonic acid 
HS  heparan sulfate 
i.v.  intravenous 
kDa  kilodaltons 
luc  luciferase 
M phase mitosis 
MCS  multiple cloning site 
MES  2-(N-morfolino)ethane sulfonic acid 
mRNA    messenger ribonucleic acid 
MTT 3-(4,5-dimethylthiazole)-2-yl-2,5-diphenyl tetrazolium bromide, thiazolyl 
blue tetrazolium bromide 
NE nuclear envelope    
NLS  nuclear localizing signal 
NPC  nuclear pore complex 
OA  oleic acid, cis-9-octadecanoic acid 
ODN  oligonucleotide 
ONPG  orthonitrophenyl-β-D-galactopyranoside 
PAMAM polyamidoamine 
 
 
 
 
PBS  phosphate buffered saline 
PCR  polymer chain reaction 
PDE-β  phosphodiesterase-β  
PDMAEG poly[N-(2-N,N-dimethylaminoethyl)glutamine] 
PDMAEMA poly(2-(dimethylamino)ethyl methacrylate) 
PEG  polyethylene glycol 
PEI  polyethyleneimine 
PG  proteoglycan 
PLGA  poly(DL-lactide-co-glycolide) 
PLL  poly-L-lysine 
PMSF  phenylmethylsulfonyl fluoride 
RISC  RNA induced silencing complex 
RPE  retinal pigment epithelium 
S phase DNA synthesis phase  
siRNA  short interfering RNA 
SV40  simian virus 40 
tk  thymidine kinase   
TEM  transmission electron microscope 
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1        INTRODUCTION 
 
Exogenous transgenes can replace or supplement the function of defective or 
malfunctioning genes.  In this sense, they can be considered to be treating the underlying 
cause, i.e. the genetic defect, of the inherited or acquired disease. In contrast, the 
conventional drugs act at the protein level, usually providing only treatment of the 
symptoms. Proteins are the building blocks of life that regulate bodily functions, and are 
regulated by genes, therefore, the lack or overproduction of specific proteins, or production 
of defective proteins affect the onset of the symptoms of genetic diseases.  
Gene medicines (or nucleic acid drugs) can be divided into different categories according 
to the method of application: gene inhibitors, gene vaccines and gene substitutes. Gene 
inhibitors are oligonucleotides (ODN) which silence defective genes, usually at the mRNA 
level, by binding (antisense, aptamer) to mRNA or by splicing it (ribozymes) in the 
cytoplasm, but also by interactions with mRNA precursor in the nucleus (Galloutzi and 
Steitz 2001). Gene vaccines are antigens of specific pathogens encoding either the genes or 
RNA that activate cell immune responses and production of antibodies (Srivastava and Liu, 
2003). Gene substitutes are transcriptionally fully competent genes introduced into cells to 
compensate for the lack of a particular protein or its insufficient protein production.  
The efficiency of gene transfer can be defined as the percentage of the cells containing 
the transgene or as the amount of transgene expression. It has been proposed that the 
replacement of a mere 5 % of the amount of protein present in normal individuals should be 
enough to achieve a therapeutic cure of hemophilia (Roth et al. 2001). As the efficiency of 
gene therapy is still being debated, it is important to know the level of gene expression that 
will be required to cure diseases. Subsequently, designing and adjustments of gene carrier 
systems can be carried out and the possible problem of overproduction of proteins could be 
avoided. Today gene therapy is still taking its first faltering steps in the field of medicine and 
the difficulty of targeting genes into cells in vivo represents the main barrier in progress. 
Also, many of the techniques available for in vitro transfections cannot be applied in vivo.    
Gene delivery methods can be divided into viral and non-viral systems. Viral systems are 
still more useful in clinical use, since they are more efficient than non-viral systems, but the 
safety issues surrouding viral systems have not been solved and even fatal adverse reactions 
have taken place in the clinical studies. These adverse reactions can be attributed to the 
random integration of transgene into chromosomal DNA that may be manifested as cancer 
and immunological responses which may lead even to the death of the patient (Raper et al. 
2003). In addition, the transgenes have size limitations and the preparation usually is more 
laborious with viral systems than non-viral systems. The control over the properties of non-
viral carriers is important in designing new gene carriers, although the main problem 
currently in polymeric carriers is overcoming their poor efficacy. The advantage of non-viral 
gene carriers over the viral systems is that usually they do not evoke immunological 
reactions, they can be completely defined and since they are synthetic, this facilitates scale-
up production. This is the ideal system and theoretically polymeric systems should be easier 
to apply than viral systems. Furthermore, if non-viral methods remain relatively simple 
carrier systems, it will be much easier to translate these techniques into practical 
pharmaceutical products. 
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2        REVIEW OF LITERATURE 
 
2.1 Non-viral gene delivery methods 
 
Non-viral gene medicines are based on either plasmids or oligonucleotides (Mönkkönen 
and Urtti 1998). The former is used in gene inhibitor medicines for silencing a defective 
gene with a piece of nucleic acid called an oligonucleotide (ODN) and the latter is used in 
gene substitute medicines for replacing (augmenting) a defective gene by a fully 
transcription competent gene delivered into the nucleus as inserted into a plasmid-DNA. 
Permanent gene transfer is not usually achieved with plasmid-based therapy, because of 
plasmid DNA´s inability to integrate into chromosomal DNA. Rather, it remains as episomal 
in the nucleus and is lost upon cell division, thereby causing only a transient effect, which is 
also usual case with ODNs.  
Gene delivery can be further divided into ex vivo, in vivo and in situ methods. In Ex vivo 
gene delivery, the cells are removed from the recipient and transfection of the therapeutic 
gene occurs outside the body, this being followed by reinfusion or retransplantation of the 
transfected cells into the recipient. Ex vivo is the most widely used method and is well suited 
to skin, liver, tumor and hematopoietic cells which can be fairly easily isolated. In vivo 
delivery, instead, is better suited to lung, brain and heart cells, and it faces more challenges 
to successful therapy than the ex vivo method. The gene of interest is administered either 
locally or systemically into the body where it has to find its way to the target tissues. 
Systemic in vivo treatment requires that there is a small carrier/DNA complex size to allow 
the penetration of the complexes into target tissues across the relatively tight barrier of 
vascular endothelial cells (Seymour 1992), and with only a marginal cationic surface charge 
to prevent binding of the complexes to negatively charged blood components. The In situ –
type of gene correction, in which an abnormal gene could be swapped for a normal gene 
through homologous recombination, is still difficult to carry out though there have been 
some successful experiments (Richardson et al. 2002).  
The non-viral gene delivery techniques used with the above mentioned methods can be 
divided into two broad categories: physical and chemical techniques.  
 
2.1.1 Physical techniques 
 
Direct injection of naked DNA (i.e., uncomplexed DNA) into the nucleus by 
microinjection (del Vecchio et al. 2005) would appear to be conceptually the most simple 
and appealing technique for delivering genes but this could only be done one cell at a time. 
Since this technique is impractical and laborious, its use is limited (i.e., for producing 
transgenic organisms). Electroporation utilizes high-voltage electric current in gene transfer. 
It is one of the most effective gene transfer techniques (Wong and Neumann 1982; Neumann 
et al. 1982), but is limited because it evokes extensive cell mortality as well as the 
difficulties in optimization and in applying in clinical use.“Gene-gun” particle bombardment 
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utilizes a high-pressure –or electrical discharge device to accelerate DNA-coated 
microscopic gold –or tungsten particles to a high velocity, forcing the particles to penetrate 
cell membranes (Yang et al 1990). Since direct exposure of the target tissue is required, this 
technique is suitable for local expression in skin, muscle or mucosal tissue, or DNA 
vaccination where a limited local expression of delivered DNA is adequate to evoke an 
immune response (Qiu et al. 1996; Fynan et al. 1993). In magnetofection, magnetic beads are 
associated with DNA complexes that are transported to the nucleus when an external 
magnetic field is applied (Krötz et al. 2003). Therapeutic ultrasound in the frequency of 1–3 
MHz can increase the transfection efficiency by increasing transiently the permeability of the 
cells (Duvashani and Machluf, 2005). 
 
2.1.2 Chemical techniques 
 
Basically, chemical carriers are the most straightforward techniques for practical use. The 
earliest chemical carriers were based on diethylaminoether-dextran (DEAE-dextran) (Takai 
and Ohmori 1990) and calcium phosphate (Chen and Okayama 1987) but their use is 
hampered by variations in the complex size, the difficulty of use in vivo studies as well as 
their cytotoxicity. The mechanism of cytotoxicity involved with chemical techniques has 
been attributed to increasing cell membrane permeability due to exposure to polycations, 
leading to collapse of the membrane potential and finally to loss of cytoplasmic proteins 
(Bashford et al. 1986). Release of endosomal contents into cytoplasm can also evoke 
cytotoxicity. Although many new techniques are being developed, such as, human artificial 
chromosome (called 47. chromosome) (Chromos Molecular Systems, Burnaby, British 
Columbia) and sleeping beauty –transposon (Horie et al 2001), the non-viral techniques 
employ mainly cationic lipids, peptides and polymers.  
Lipids may be the most frequently used chemical carriers but they suffer from several 
drawbacks including lack of targeting, poorly understood structure of lipoplexes and 
variations arising during fabrication. The charges of cationic head groups are either 
monovalent or multivalent, having either tertiary or quaternary ammonium groups. The latter 
is more efficient in gene delivery but it is also more toxic. The most commonly used lipids 
include monovalent N-(1-(2,3-dioleyloxy)propyl)-N,N,N-trimethyl ammonium methyl-
sulfate (DOTAP) (Eibl and Wooley 1979) and dioleyloxypropyl trimethyl ammonium 
bromide (DOTMA) (Felgner et al. 1987), and the multivalent dioctadecylamidoglycyl-
spermine (DOGS) (Behr et al 1989), and dipalmitoyl phosphatidylethanolamidospermine  
(DPPES) (Behr et al 1989). The role of the neutral “helper” lipid DOPE is to facilitate 
cytosolic release of DNA by fusion with and disruption of the endosomal membrane 
(Litzinger et al. 1992; Farhood et al 1995). Positively charged liposomes do not usually exist 
naturally in cells being either neutral or negatively charged. Encapsulation of pDNA into 
liposomes has proven to suffer form a lack of efficiency, therefore, its use has been limited 
(Nicolau and Cudd 1989).  
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Two types of peptides or proteins are used for gene delivery purposes. Poly-L-lysine 
(PLL), poly-L-ornithine and poly-L-arginine  (Pouton et al. 1998) are able to condense DNA 
and mediate gene transfer as such, while membrane-destabilising and lytic fusogenic 
peptides  (i.e. HA2, Gal4, JTS-1, GALA, KALA), and nuclear localization signals, NLS-
peptides, (i.e TAT) are used as auxiliary agents. Arginine- and histidine-rich peptides can 
help to promote endosomal escape, e.g. the endosomolytic activity of arginine-rich 
protamine has been shown to enhance cationic liposome-mediated delivery in vitro (Sorgi et 
al. 1997) and in vivo (Schwartz et al 1999).  Poly-L-histidine (Uster and Deamer 1985),  
JTS-1 (Gottschalk et al.1996) GALA and KALA (Nir et al. 1999; Parente et al. 1988; 
Wyman et al. 1997) mediate an acid-dependent fusion and leakage of negatively charged 
liposomes. GALA and KALA undergo a pH change-dependent conformational change 
before adopting an amphipathic structure. The cationic NLS moiety consists of basic amino 
acids and can mediate the transport of DNA to the nucleus by promoting its binding to a 
carrier protein called importin (but this also affects the rate of the nuclear transport) 
(Nakanishi et al. 2001; Zanta et al 1999; Svahn et a. 2004). 
 
2.2 Polymeric gene delivery systems 
 
Cationic DNA condensing polymers are used to overcome poor cellular uptake of naked 
DNA, due to the high molecular weight (>106) and highly negatively charged nature of 
DNA. Only in some dense tissues, i.e, muscle, can fairly high cellular uptake and 
transfection efficiency be achieved by a non-condensed DNA system. In this case, DNA is 
coated with protective, interactive and neutral polymers that allow DNA to retain its 
flexibility, and thus, promote high diffusivity within the tissue. Some natural and synthetic 
polymers (i.e., poly(DL-lactide-co-glycolide), PLGA) which are biodegradable and often 
negatively charged can be employed in substrate-mediated delivery. A polymeric scaffold 
assists in supporting cell adhesion and migration and transports the immobilized DNA 
directly into the cellular microenvironment, providing a controlled release systems for DNA 
delivery (Segura and Shea 2002).  
One important and frequently used transfection parameter of non-viral gene delivery 
systems is the charge ratio, which means nucleotide equivalents, the ratio of the cationic 
carrier nitrogens to DNA phosphates (N:P) (Boussif et al. 1995). Successful transfection is 
dependent on many different factors including charge ratio, cell line, medium composition 
(especially salt concentration), the aggregation of complexes, the number of primary, 
secondary and tertiary amines in the carrier, the side-chain length, molecular weight, the 
hydrophilic components and the chemical structure of the carrier. Usually, polymeric gene 
delivery systems have linear, branched, dendritic or grafted structures. The structures of 
some non-viral polymeric carriers are presented in Figure 1.  
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2.2.1 Structures and properties  
 
Structure of plasmid-DNA – Successful gene expression requires some crucial elements 
in  the  synthetic  circular  plasmid-DNA  (pDNA)  expression  cassette.  Promoter  provides  
recognition sites for RNA polymerase to initiate the transcription process and it also controls 
the transgene expression, the transgene of interest is inserted into the MCS (multiple cloning 
site), a poly (A)-sequence is required for termination of transcription and the ORI (origin of 
replication) is the initiation site for replication which also defines the copy number of 
plasmid molecules for stable episomal transfections. Sometimes introns are also needed, 
although they are usually not present in cDNA, since it is prepared from mRNA by reverse 
transcription. The next chapters will focus mainly on the cationic polymeric carriers used for 
condensing of pDNA. 
 
Poly-L-lysine – Histone, the condensing agent of genomic DNA contains a high 
proportion of the basic amino acid, lysine. Therefore, synthetic polylysine (PLL) has 
maintained the scientific interest and there have been supporters of its usability in gene 
delivery since the early ages of non-viral gene delivery. Linear PLL has only primary amine 
groups on its side chains (Fig. 1) but a high charge density, and thus, a high affinity for DNA 
at physiological pH leading to strong binding with DNA (Zama et al. 1971). This is why 
PLL fails to undergo a rapid release from complexes and this also impacts on its transfection 
ability. Some studies have shown that at low salt concentrations, the interaction of PLL with 
DNA is irreversible, i.e., PLL and DNA molecules do not exchange with free PLL and DNA 
in the medium (Tsuboi et al., 1966), but at high salt concentrations (~ 1 M NaCl) this 
interaction occurs readily due to the high degree of hydration of the complexes. Due to the 
fairly rigid structure of PLL, it usually forms large insoluble clusters with DNA (up to some 
microns in size) (Kabanov, 1998b). Unlike most non-viral gene carriers, PLL may have 
immunogenic and toxic properties due to its amino acid backbone, especially the high 
molecular weight PLLs (Wolfert and Seymour 1996). Furthermore, the L-form of polylysine 
is biodegradable though the D-form is not (Laurent et al. 1999). Since PLL as suchs seem to 
function with variable success in gene delivery, different modifications have been developed 
to improve its efficiency in transfections. One significant advantage is that it can be fairly 
easily modified, i.e., conjugated with ligands, for cell specific targeting. 
 
Poly(ethyleneimine) – PEI has become a traditional polymer used in gene delivery 
because of its efficiency of transfer into a fairly broad range of cell lines. This branched 
polymer of ethylamine is a weak polybase with a unique structure containing primary (25 %, 
Kichler et al. 2001), secondary (50 %) and tertiary (25 %) amines (Fig. 1). Correspondingly, 
the linear PEI has only secondary amines, and consequently, it is a less efficient condensing 
agent than its branched counterpart (Dunlap et al., 1997). Somewhat polydispersed branched 
PEI is a flexible polymer which forms DNA complexes with a hydrophobic core and a 
positively charged surface. Along with increasing molecular weight, the cytotoxicity  of  PEI  
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is increased (Fisher et al. 1999). Every third atom in PEI has an amino nitrogen providing it 
with the highest possible cationic charge density of any molecule (Suh et al. 1994). 
However, only one out of six of all nitrogen atoms (~ 17 %) are protonated in 10 mM 
aqueous solution (pH 7.4) (Boussif 1995), and therefore, neutral polyplexes of PEI 25 kDa 
are not obtained until there is a N:P ratio of 3.5 (Erbacher et al. 1999). The remaining amine 
groups retain the ability to become charged at lower pHs, thereby providing PEI with a high 
buffer capacity. The mechanism of the function of PEI in gene delivery has been explained 
by the “proton sponge” hypothesis. Due to the acidification of endosome, positively charged 
protons enter the endosome, protonating the previously uncharged tertiary amines on the 
PEI. The high concentration of positive ions results in an inflow of negative ions (restoring 
the electrical gradient in the endosome), which then leads to endosome swelling and eventual 
bursting of the endosome, thus releasing the DNA into cytoplasm. However, this hypothesis 
has been challenged by the observation that PEI can escape from the endosomes prior to 
their acidification (Godbey et al. 2000).  
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Figure 1.  Chemical structures of some polymeric pDNA carriers.  
 
Dendrimer – Polyamidoamine dendrimers (PAMAM, Starburst dendrimer) are 
synthesized stepwise by building up spherical shells around the core molecule (Fig. 1). Each 
new shell forms a generation and the molecule can continue growing until steric hindrance 
prevents addition of the next generation (Esfand and Tomalia 2001). Generation zero 
includes the core molecule and each new generation results in a two-fold increase in the 
number of  available  primary  amino  groups  on  the  surface.  The  polydispersity  of  these  
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molecules is very small because of the strictly controlled surface charges. Intact dendrimers 
with  an  integrated structure have  proven to be less efficient  in gene delivery  than partially  
degraded, so-called “fractured”, dendrimers  (Tang  et  al. 1996).   The “fractured” dendrimer 
is a more flexible molecule than the intact form and it is able to expand due to an increase in 
the positive charge at lower pH (Tang et al. 1996), as is the case of branched PEI, which 
supports the idea that “fractured” dendrimers act as proton sponges. Although some 
generation-dependent cytotoxicity has been seen associated with dendrimers, in general, 
these compounds have exhibited relatively low levels of toxicity (Roberts et al. 1996). 
Linear polyamido amines have shown molecular weight-dependent and charge density-
dependent cytotoxicity (Hill et al. 1999). 
   
Methacrylate – The first amino methacrylate polymer to be evaluated for its ability to 
mediate gene transfer was the linear poly(2-(dimethyl-amino)ethyl methacrylate) 
(PDMAEMA) (Cherng et al. 1996). Cherng et al. (1997, 1999) showed that with freeze-
drying, PDMAEMA/plasmid complexes formed in >2 % sucrose solution retained their 
transfection ability for a ten month period. A long shelf-life is a major advantage for a 
polymeric gene delivery vehicle in comparison with viral carrier systems. Unmodified 
PDMAEMA containing only tertiary amino groups has proven to be almost as efficient a 
transfection vehicle as PEI in some cell lines but some cytotoxicity was noted to be present 
(Dubruel et al. 2003). Other methacrylate-based polymers containing pyridine groups, acidic 
groups and imidazole groups have been generated and tested (Dubruel et al. 2003). Using 
monomers with varying pKa values, some of the polymers containing imidazole groups or 
acid functions provided a buffering capacity comparable to PEI at endosomal pH. However, 
due to a possible restriction in cellular uptake, it remains unclear whether a “proton sponge” 
occurs with these polymers.  
 
Poly(ethylene glycol) – The apparent simplicity and lack of chemical activity has made 
polyethylene glycol (PEG) a widely used stabilizing surface coating for complexes in 
biological environments. PEG is an uncharged hydrophilic polymer possessing high water 
solubility, but due to its amphiphilic nature it is soluble also in organic solvents. Since it is a 
flexible molecule, PEG can adopt different states in aqueous solutions. PEG has been 
considered to be biologically inert, however, it can form directional bonds with water 
(Antonson and Hoffman 1992) and it can bind to proteins (Sheth and Leckband 1997). Also, 
certain molecular weights PEG were shown to induce membrane destabilization and fusion 
(Kuhl et al. 1996). Due to the lack of any immunogenic effect (Nguyen et al. 2000), the non-
toxic nature and the extended lifetime in the body because of the reduced cationic surface 
charge, PEG has been widely studied, especially in vivo. However, the prolonged blood 
circulation time of PEGylated complexes is not undisputed (Mullen et al. 2000). The 
presence of PEG is expected to improve solubility, leading to less aggregated complexes 
which are stable also  at high concentrations. PEGylated  PLL  (Katayose and Kataoka 1997)  
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and PDMAEMA (Rungsardthong et al. 2001) have been shown to form more stable DNA 
complexes, but in the case of PDMAEMA at the expense of a reduced level of transfection. 
In addition, PEG does not significantly reduce the buffering capacity of the PEGylated 
PDMAEMA (Rungsardthong et al. 2001). 
 
Block-co-polymer – Block copolymers are heteropolymers consisting of two or more 
blocks, groups of repeating polymers, in the main chain. The block copolymers proposed for 
gene delivery usually contain polycationic and hydrophilic blocks (A-B type), for example, 
PEGylated PLLs belong to this type, but also, A-B-A type copolymers are used. The cationic 
block can associate with DNA, thereby, inducing complex formation and the hydrophilic 
block is likely to remain orientated towards the solvent forming nonionic hydrophilic corona 
on the surface of the complex.   
 
2.2.2 Complex formation 
 
The conformational change of DNA from an elongated into a compact state is called 
“DNA condensation.”The condensation phenomenon was first discovered by Lerman 
(1971). Understanding of the processes involved in DNA condensation is essential for the 
optimization of gene delivery systems. In addition to cationic liposomes, polymers or 
peptides, DNA can be condensed with various chemical agents including neutral polymers, 
such as, PEG together with a salt (Laemmli). Intramolecular condensation occurs within 
milliseconds (Porschke 1984; Xu and Szoka 1996; Gershon et al 1993) leading to the 
formation of small self-assembled particles with an orderly morphology and finite size.  
 
Mechanism for DNA collapse – Electrochemical theory and thermodynamics are the 
basis of DNA condensation, although electrostatic interactions are highly attenuated in water 
because of dielectric constant of the water. In aqueous solution, the negative charges of DNA 
molecule (one charge/1.7 Å) are neutralized by monovalent counterions. It has been 
proposed that DNA condensation is induced when ~ 90% of the charges are neutralized by 
multivalent cations (Wilson and Bloomfield 1979; Stevens 2001). Entropy gain is the driving 
force for complex formation (Manning 1978). Due to the negative net charge of two DNA 
chains and non-electrostatic repulsive contributions (i.e., steric repulsion), DNA chains repel 
each other, thus, entropy is low and DNA packaging is entropically disfavoured. The role of 
a polymer carrier in condensation is to reduce the electrostatic repulsions of adjacent 
negatively charged DNA segments. They also cause a heterogenous charge distribution 
along the DNA chain, leading to a counterion-mediated attraction, thereby increasing the 
entropy of the DNA and finally leading to condensation of DNA.  
Polyvalent polymers introduced into a DNA solution will replace the monovalent 
counterions because of the polymers` higher affinity towards DNA, which readily undergoes 
a structure transition to its secondary or tertiary structure, allowing each molecule to collapse 
into a compact soluble colloidal particle (Fig. 2 ).  
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Figure 2. Polyplex formation.  Nitrogen atoms of the polymer neutralize phosphates on the DNA, leading 
to collapse of DNA and complex formation, usually to the size of 50–300 nm. The complex should be 
stable under physiological conditions but be able to disassemble and release the DNA for transcription. 
 
Condensation depends on the characteristics of the solvent, i.e., temperature, salt 
concentration, dielectric constant, etc. For example, salt has the effect to retard the folding of 
DNA. The collapse induced by multivalent cations is stronger than that achieved by 
monovalent cations. The critical cation concentration necessary to induce DNA compaction 
decreases as the valencey of the cation increases, being lowest for tetravalent and highest for 
monovalent cations. Unlike monovalent counterions, polyvalent counterions do not only 
reduce the DNA backbone charges, but they make the charge distribution very 
heterogeneous since they can neutralize more than one backbone charge.  
 
Morphology of the complexes – Although heterogeneity in size and shape of self-
assembled systems is a common feature for carrier/DNA complexes, certain regularities have 
been shown in polyplex formation. The most commonly seen morphology in compact DNAs 
is a toroid form. Sizes of about 45–200 nm have been described with 3 kbp plasmid and 166 
kbp T4 DNA molecule, respectively (Shen et al. 2000; Yoshikawa et al 1999). The density 
of the DNA strands compacted into a toroidal form can be relatively high, thus, small 
particles as tiny as ~ 20 nm (theoretical minimum) can be formed. Some PLL-based 
polyplexes have been shown to have a volume of mainly about 30–35 nl and a height about 
4–6 nm, indicating that most often one plasmid-DNA is condensed into one complex (Golan 
et al. 1999; Bloomfield 1998; Sergeyev et al.1999). There are atomic force microscopy 
(AFM) experiments revealing that DNA truly forms toroids also in the solution (Martina et 
al. 2000; Golan et al. 1999), these being somewhat larger than as dried form. Thus, toroids 
are not an artefact occurring in the dried form only, which sometimes has been considered, 
since most experimental imaging methods involve dehydration of the samples. The 
mechanism by which toroids are formed is explained as follows. Since DNA does not favor 
tight bending, its stiffness sets limits on tight curves, and therefore, to minimize the loss of 
energy associated with bending accompanied by folding under a poor solvent (due to charge 
neutralization, hydrophobicity increases) DNA wraps itself in a circle with a hole at the 
centre (see Fig. 3) (Marx et al. 1987). It has also been hypothesized that rod-like structures 
may open up, forming a toroid (Dunlap et al. 1997) leading to a conclusion that rod-like 
complexes might be meta-stable structures (Bloomfield 1991). The ultrastrucuture of the 
complexes is difficult to explore, and is still something of a mystery. 
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Figure 3. Phase diagram of the morphology of DNA complexes deduced from theoretical calculations 
(modified from Noguchi and Yoshikawa, 1998). The image of pDNA from K. Yoshida et al. (Biophys J., 
1998). 
 
A simulated phase diagram of compact state DNA, depicting the changes of the 
condensing polymer stiffness is shown in Figure 4. A rigid polymer forms a toroid or rod-
like structures with DNA depending on the degree of attraction between DNA segments and 
the stiffness of the condensing polymer (Noguchi and Yoshikawa, 1998). A flexible polymer 
forms a spherical compact state with less dense liquid-like packing, and when attractive 
interactions become sufficiently strong, they form spherical solid-like particles. 
 
Stability of the complexes – Aggregation of the complexes would prevent their use, and 
therefore, the surface charge of the complexes must be optimized. Increasing amount of 
polycations added to the non-stoichiometric, low concentration DNA solution decreases the 
negative complex charge and increases the proportion of the hydrophobic sites (Kabanov and 
Kabanov 1998) (Fig. 4). The residual electrical charges on the complexes prevent 
aggregation. At some point, all of the DNA charges are neutralized by the polycation and the 
hydrophobicity of the complex increases, leading to an increasing proportion of water 
insoluble stoichiometric complexes. Further addition of the polycation may lead to 
recharging of the complex and its solubilization. The complexes must be stable against not 
only aggregation but also extracellular and intracellular substances, which have a 
polyanionic nature (i.e. GAGs). This is because too rapid dissociation in the cytoplasm may 
lead to extensive degradation of plasmid DNA, and too slow dissociation may lead too weak 
transgene expression due to impaired accessibility of the transcription factors.  
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Experimental and computational data indicates that the binding energy and subsequent 
polycation-DNA complex stability is dependent on the quality of polycation amines, being 
most stable with primary amines followed by secondary, tertiary and quaternary amines 
(Reschel et al. 2002; Dybal et al 2004). In addition, ion-exchange between monovalent and 
multivalent cations plays a major role in stabilizing the complexes.  It is noteworthy that a 
complex containing equal amounts of phosphate and amino groups may still carry a net 
positive or negative surface potential, if the complex do not allow the neutralization of all 
charged groups due to differences in amine pKa´s.  
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Figure 4. Effect of polycation/DNA ratio on the electrical charge of complexes. Binding of polycation to 
the DNA neutralizes the phosphate group charges.  Small amounts of polycation on the DNA leads to 
negatively charged complexes due to the excess of DNA. With an increasing amount of the polycation, 
the net negative charge becomes the positive. At the equivalency point (equal amounts of DNA and 
polycation) soluble complexes precipitate but further addition of polycation may lead to the recharging of 
complexes and their solubilization. Near to neutrality, complexes usually have a strong tendency to 
precipitate and form aggregates, whereas complexes carrying a net negative or positive charge are 
relatively stable.  
                                                                                                                                                                                                     
2.2.3 Mechanism of DNA release  
  
    Important as complex formation is for gene delivery, complex dissociation or relaxation is 
an equally crucial factor. It is generally thought that DNA must be released from the carrier 
before it is transcribed, although there is some evidence that DNA can be transcribed also 
from complexed DNA. At N:P ratios of 5 and up to 15, transcription of the PEI complexed 
plasmid was as efficient as that of the free plasmid (Honoré et al. 2005). Even if DNA 
release from the complxes is required, it is not known, however, at which point this release 
should  happen, before or  after  the  nuclear  uptake.  Premature release of DNA may lead to  
 
 
 
 26
 
degradation of unprotected DNA. Although the mechanism of release is not precisely 
known, it has been proposed that polyions exchange and substitution reactions (flip-flop), 
may play a significant role in release of DNA in its active form (Kabanov 1992; Xu and 
Szoka, 1996). This is based on the fact that the carrier incorporated into the polyelectrolyte 
complexes may be exchanged by the free carrier from the bulk solution, and this involves a 
dissociation mechanism. It has also been shown that an excess of anionic liposomes or 
anionic polysaccharides, such as heparin, can release a substantial amount of the DNA from 
the lipoplexes (Xu and Szoka, Jr 1996).  
 
2.3 Intracellular distribution and kinetics of plasmid-based systems  
 
A better understanding of the intracellular distribution and kinetics of plasmid-based 
systems would be useful in the optimization and design of new gene delivery systems. A 
kinetic model to analyze rate-limiting processes of intracellular kinetic and optimize 
intracellular trafficking of internalized plasmid DNA has been developed (Varga et al. 2001; 
Kamiya et al 2003). This poor quantitative knowledge of intracellular distribution of plasmid 
DNA in each subcellular compartment (endosomes, lysosomes, cytoplasm and nucleus) is a 
disadvantage for the modelling.   
 
The steps involved in gene transfer are presented in Figure 5. Positively charged 
complexes attach to the negatively charged plasma membrane which forms a pit and pinches 
off, forming an endosome. The complexes must escape from the endosomes before they are 
attached by degradative lysosomal enzymes. The DNA, complexed or free, must diffuse 
through the cytoplasm into the nucleus where it can be transcribed into mRNA which is 
translated into the appropriate protein in the cytoplasm.  
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Figure 5. Steps in polycationic-mediated gene transfer. Positively charged cell-surface attaching complex 
is internalized into an endosome. Thereafter, the complex is released from the endosome or the 
endolysosome and transferred into the nucleus where the DNA will be transcribed into mRNA, and 
finally, translated into a protein in the cytoplasm. The newly synthesized protein can be used for the 
intracellular processes (e.g constituents of the cellular enzymes), transferred to the cell surface (e.g. cell-
associated PGs) or secreted outside the cells (e.g. hormones). 
 
2.3.1 Binding and internalization  
 
Extracellular materials are taken up by cells via phagocytosis or pinocytosis (fluid-phase 
endocytosis). The latter process involves clathrin-dependent receptor-mediated cellular 
uptake and clathrin independent adsorptive cellular uptake (Alberts et al 1994a; Nichols et 
al. 2001). Possible alternatives to clathrin-mediated endocytosis include caveolae or actin-
based mechanisms. Most often the clathrin-dependent endocytosis seem to be responsible for 
cellular uptake of complexes (Clark and Hersh 1999; Meyer et al 1997). The mechanism for 
uptake of the complexes is thought to be as follows: Positively charged complexes attach to 
negatively charged cell membrane or to the receptor at the plasma membrane. The stimulus 
results in a localized polymerization of actin at the site of particle attachment and subsequent 
invagination of endocytosed material and plasma membrane components, forming a vesicle 
which rapidly buds off (Greenberg et al. 1990). Clathrin coated vesicles rapidly lose their 
coats, facilitating their fusion with early endosomes. The acceptor of the polyplexes at the 
plasma membrane may be sulfated glycosaminoglycans (such as heparan sulfate or 
chondroitin sulfate) or phospholipids themselves (Farhood et al 1995). It is noteworthy that 
only a small fraction, less than 15 %, of cell-associated DNA is released into the cytoplasm 
(Legendre and Szoka 1992; Felgner et al. 1987). 
 
 
 
 28
 
The particle size is important in terms of selective internalization via receptor-mediated 
endocytosis and this might determine the mechanism of internalization. Large complexes 
(several hundreds of nm) may enter the cell either by phagocytosis or clathrin independent 
endosytosis, whereas small complexes (<200 nm) can be internalized by non-specific 
clathrin dependent endocytosis (Simões et al. 1999).   
  
2.3.2 Endosomal escape 
 
The endosomal membrane is the first barrier in the intracellular trafficking of plasmid 
DNA. Viruses have developed a sophisticated pH-dependent mechanism to escape from 
endosomes. This is mimicked by incorporating or adding fusogenic amphipathic peptides in 
the non-viral vectors (Plank et al 1994; Wagner 1999). Internalized complexes end up first in 
the early endosomes, which are slightly acidic vesicles (pH ~ 6.0–6.8) maintained by an 
ATP-driven proton pump (Al-Awqati 1986; Mellman et al 1986; Forgaq et al 1992) 
promoting dissociation of many ligand-receptor complexes. Early endosomes fuse with late 
endosomes which are responsible for accumulating and digesting exogenous and endogenous 
macromolecules in conjugation with the lysosomes (pH ~ 4–5, Mukherjee et al. 1997). DNA 
which is on its way into the nucleus has to escape from endosomes before they fuse with 
lysosomes. Thereby it avoids degradation by lysosomal enzymes. The mechanism for 
endosomal escape is based on the loss of membrane asymmetry (Fattal et a. 1994; Bevers et 
al. 1994).  Then the mechanical or osmotic stress can rupture the endosomal bilayer, thus 
releasing the DNA into the cytoplasm. Loss of clathrin and the accessory proteins during the 
uncoating of the vesicles might make the uncoated vesicles more prone to rupture than the 
plasma membrane (Xu and Szoka 1996). A similar mechanism has been described with 
biodegradable PLGA and is based on selective reversal of the surface from being anionic to 
becoming cationic in the complexes in acidic surroundings. This then leads to an interaction 
between the complex with the membrane and its escape from the lysosomes (Panyam et al. 
2002). Although there is no agreement on whether PEI polyplexes are able to destabilize 
endosomal membranes (Kichler et al. 2001; Klemm et al 1998; Godbey et al 1999), the 
“proton sponge” hypothesis is the most popular explanation to account for endosomal 
escape. PLL polyplexes escape rather inefficiently from internal vesicles, but when free or 
complexed PEI is used as an auxiliary agent, the ability to escape from endocytic vesicles is 
enhanced (Kichler et al. 2001).   
Only a small fraction of the internalized complexes is able to escape from endosomes and 
reach the cytoplasm, the majority appears to be trapped and eventually degraded within the 
lysosomes (Plank et al. 1994; Zabner et al. 1995; El Ouahabi et al. 1997; Wattiaux; 2000). 
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2.3.3 Diffusion in cytoplasm 
 
Cytoplasm is composed of a network of microfilaments and microtubule systems which is 
responsible not only for the mechanical resistance of the cells but also for the cytoplasmic 
transport of organelles and macromolecules (Luby-Phelps 2000). The cytoskeleton is 
embedded in fluidic cytoplasm which has approximately the same viscosity as water 
(Fushimi and Verkman 1991; Luby-Phelps et al. 1993), however, this does depend on the 
cell type and spatial location (Srivastava and Krishnamoorthy 1997). The diffusion of 
plasmid DNA is greatly impeded in cytoplasm (Dowty et al. 1995). DNA fragments sized of 
2 kDa have very limited mobilities in the cytoplasm and diffuse >100 times more slowly in 
cytoplasm compared to water (Luckacs et al. 2000). This can due to many factors: i) the 
presence of organelles in cytoplasm, ii) the mesh-like structure of the cytoskeleton, acting as 
a sieve, and iii) the high protein concentration (up to 100 mg/ml) promoting binding to 
intracellular components (Luby-Phelps 2000). In this light, it appears that the constituents of 
cytoplasm are able to create a diffusional barrier to transport plasmid DNA near the nuclear 
envelope. 
 
2.3.4 Nuclear uptake 
 
The purpose of a nuclear envelope (NE) is to preserve the stability of chromosomal DNA 
and to protect it from the intrusion of exogenous substances, and therefore, the penetration of 
the membrane is not an easy task for DNA. NE is composed of a double lipid bilayer and 
transport between cytoplasm and nucleus is regulated by nuclear pore complexes (NPCs), ~ 
10 nm width (central canal) and 50 nm length, which restrict the passive diffusion of globular 
molecules up to ~ 40–70 kDa (Paine et al.1975; Hicks and Raikhel 1995; Görlich and Mattaj 
1996) this being especially difficult, as the size increases. Facilitated diffusion requires an 
interaction with NPC components before internalization. The outer diameter of NPC is 
estimated to be about 100 nm, and therefore, particles much larger than that should not even 
theoretically be able to pass through the nuclear pores. (Nakanishi et al 2001). NPC can 
convert from an acting simple sieve that separate two compartments into a smart barrier that 
adjusts its permeability according to the metabolic demands of the cell (Mazzanti et al. 
2001). The diameter of NPCs can vary by up to several tens of nm according to cell type and 
cell cycle (Dworezky et al. 1988; Maul 1977; Miller et al. 1991; Feldherr et al 2001). 
Electrical voltage across nuclear envelope is attributable to the electrical charge separation 
due to selective membrane permeability and the unequal distribution of charged 
macromolecules across NE, and thus, nucleocytoplasmic transport may be driven by 
electrical gradients (Mazzanti et al. 2001).  
Since polyplexes are polydisperse systems of various sizes, and plasmid DNA (3–11 kb) 
itself has a radius of gyration of about 90–130 nm (Sebestyen et al.1998), the mechanism of 
nuclear uptake through NPCs is not obvious, and therefore, it has been proposed that only 
when  the  nuclear  membrane  break  downs during mitosis, is pDNA capable of penetrating  
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into the nucleus (Tseng et al 1999). However, it has been shown that plasmid DNA can also 
enter the nucleus of non-dividing cells (Ludke et al.). Many research groups have shown that 
cytoplasmic DNA, either complexed with a carrier or microinjected, is taken up poorly into 
the nucleus of cells and not more than 0.1–0.01 % of the cells become transcribed. (Capecchi 
1980; Zabner et al.1995; Labat-Moleur et al. 1996; Pollard et al 2001). Moreover, naked 
DNA does not have a nuclear targeting component, thus its efficiency at traversing into the 
nucleus as a free molecule is low. Signal-mediated import of exogenous DNA based on 
NLS-conjugated carrier systems (Sebestyen et al. 1998; Branden et al. 1999; Ludke et al. 
1999; Wilson et al.1999; Zanta et al. 1999) or NLS containing transcription factors (Dean 
1997; Dean et al. 1999; Wilson et al. 1999) have enhanced nuclear uptake and transgene 
expression. This, however, does not exclude the possibility that DNA can also be transported 
through NPCs by an NLS-independent mechanism. Furthermore, transport of 
macromolecules through NPCs can be inhibited by conformational changes of the NPCs due 
to the low concentration of Ca2+in the NE. Therefore, cellular events altering the Ca2+ 
concentration in the NE can obstruct the pathway through the NPC being used by 
macromolecules (Pante and Aebi 1996) and this would be expected to be reflected at the 
level of gene activity and gene expression due to the impeded translocalization of mRNA or 
transcription factors (Mazzante et al. 2001; Burg et al.1996, Hardingham et al.1997).  
Macromolecules, such as, nucleic acids, can also be excluded from the nucleus, thus 
decreasing the amount of nuclear exogenous DNA, leading to low transgene expression. 
Nucleic acids larger than 250 bp have been shown to be excluded from nuclei (Swanson et 
al. 1987; Luckacs et al. 2000).  
 
2.3.5 Degradation of DNA  
 
Since foreign DNA within cells is a sign of an intruder, naked exogenous DNA is rapidly 
eliminated both in the extracellular or intracellular environments by Ca2+-sensitive endo- and 
exonucleases, leading to a low efficiency of gene transfer (Lechadeur et al.1999). Nucleases 
recognize the phosphodiester linkage in the DNA backbone and this leads to hydrolytic 
degradation of DNA. The half-life of plasmid DNA can be increased when it is stabilized by 
liposome encapsulation or incorporated into phospholipid vesicles (Lechardeur et al 1999; 
Wheeler et al. 1999) but also many chemical DNA carriers prolong the half-life. For 
example, PEI, can improve the pharmacokinetics of DNA by protecting it from degradation 
before it has reached the site of action. Plasmid DNA degradation is faster from complexes 
with poly-L-lysine than with poly-D-lysine, since poly-L-lysine is a biodegradable molecule 
(Laurent et al. 1999). A quantitative assessment of the decay kinetics revealed that 50 % of 
the microinjected DNA was eliminated within 1–2 hours in HeLa and COS cells (Lechardeur 
et al. 1999). Also, the rate of intracellular degradation of the plasmid DNA within 1–4 days 
was estimated to be 4.5–10 and 8–15 copies/cell/min for 293 and HepG2 cells, respectively 
(Kichler et al. 2001). It seems that the majority of the DNA does not participate in the 
expression of the transgene.  Most of  the DNA is  trapped either inside vesicles or within the  
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cytoplasm and this is degraded by the cell more or less immediately, depending on the 
amount of delivered DNA, the cell type, and the capacity of the carrier to protect DNA from 
degradation (Kichler et al. 2001).  
  
2.4 Control of transgene expression  
 
Transcription requires the presence of transcription factors but the synthesis starts with 
the binding of RNA II polymerase (eukaryotes) at the promoter, the unit that directs the 
synthesis of mRNA, which directs the synthesis of proteins. Promoters vary in their 
efficiency to bind RNA polymerase and weak promoters may require transcription 
enhancers. 
Uncontrolled expression of foreign proteins may disturb the physiology of the host cell, 
and therefore, control over transgene expression is essential. Furthermore, the foreign gene 
should preferably be expressed only in certain tissues in order to maintain the organism´s 
normal physiology. This can be achieved by selecting an appropriate tissue-specific 
promoter or targeting the therapy only to certain cells. If the moment of time and the level of 
transgene expression could be controlled, this would help to tune the efficiency and improve 
the safety of gene-based therapies to the level that gene therapy could become an established 
form of treatment. Delivery of gene transcription regulating proteins may have offer this 
kind of capability. Cell-permeable peptides (CPP) are able to transport other proteins (i.e. 
gene transcription regulating proteins) into the cytoplasm and nucleus where they can 
upregulate or downregulate targeted genes either by binding to DNA or mRNA or 
alternatively by perturbing specific protein-protein interactions (Järver and Langel 2004). A 
“Gene switch” is a regulatable gene expression system that can be switched on or off by an 
external inducer, e.g., by the antibiotic tetracycline, which activates transcription factors and 
their target promoters (Goverdhana et al. 2005). Ideally, these switches permit limited 
transgene expression at a defined level. siRNA (short interfering RNA) is a natural 
mechanism used by the body to transiently silence certain genes. The mechanism is activated 
when cytoplasmic RNase, a so-called Dicer, splices long dsRNA (double stranded) into 
oligonucleotides (~21–23 nucleotides), which then become attached to silencing complex 
called RISC (RNA Induced Silencing Complex) guiding this complex to the complementary 
site at target mRNA, which will be spliced by the RISC (Mello and Conte 2004). 
 
2.5 Cellular properties affecting gene delivery 
 
2.5.1 Cell division cycle 
 
The cell division cycle can be divided into four phases, G1 (Gap1), S (synthesis), G2 
(Gap 2) and M (mitosis) (Fig. 6). G1 and G2 phases are interphases in which cells mainly 
grow  and  monitor  their  size  and  the  environment. During  the  S phase, the chromosomal  
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DNA and other organelles and cellular contents are replicated prior to their division into 
daughter cells. In the G2 phase, the  cells  also  check  whether  the  newly  synthesized  
DNA  is  flawless  and  the environment is favorable for proceeding to the last phase, 
mitosis, in which the cells divide. Sometimes cells can pause in their progress and exit from 
the cell cycle to a phase called G0. Basically, cells can rest in this phase for an indefinite 
time before entering the cycle again. The transition from one cell cycle phase to another is 
regulated by cyclin-dependent protein kinases (Cdk) but other factors, such as, soluble 
growth factors, insoluble extracellular matrix molecules, mechanical force or cell distortion 
can all contribute to the control of cell cycle phase and each factor can be rate-limiting step 
for the others (Huang and Ingber 1999). Normally, cell proliferation is tightly controlled but 
sometimes when the control fails, the cells can be converted cancerous cells. 
 
3) G2 (Gap 2):
G2
  
S
G1
serum
deprivation
thymidine
block
M  
1) G1 (Gap 1)            
2) synthesis (S): 
DNA replication
4) mitosis (M):
Cell division
G0: Cells rest
(days/weeks/months)
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Cell division cycle. The lengths of the phases and cell cycle are dependent on the cell type but 
generally the length of one cycle is at least 12 h. The illustration includes the cell synchronization 
treatments. Serum deprivation arrests the cell cycle at the beginning of G1 phase and double thymidine 
blocking arrests the cells at the boundary of G1/S phases. Cells monitor their cell cycle during the G 
phases, any problem with the cell size, environment or DNA replication may prevent cell cycle 
progression from one phase to another.   
 
 All of the changes that cells undergo during cell division cycle are still not completely 
understood. The cell volume (Fidorra et al.1981) and intracellular pH (Musgrove et al. 1987) 
are both dependent on the cell cycle phase and both tend to increase toward mitosis. This 
may due to the proton pump activation during cell growth phase (Imai and Ohno 1995). 
Certain cell organelles, such as lysosomes, react to a change in the intracellular pH by 
changing their localization and shape (Heuser 1989). The nucleolus is a membraneless 
organelle within the nucleus and its size and morphology reflects the cell cycle phase and 
transcriptional activity. Cells prepare themselves to enter mitosis by increasing the tension of 
the plasma membrane, decreasing the rate of endocytosis and depolymerizing the 
microtubules – the structures responsible for trafficking of cellular organelles such as 
endosomes and lysosomes. Intranuclear negativity follows the charges of chromatin, being 
lowest at the end of mitosis, when chromosomes are in a condensed state and the charges of 
the DNA are partially neutralized  by  positively  charged histones, and  thereafter  negativity  
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increases until G2 phase when it is at its highest, before the condensation takes place. The 
nuclear envelope disappears and reconstitutes at each cell division. Reassembly of the 
envelope is completed within 15 min after a cell division (Robbins and Gonatas 1964; 
Feldherr and Akin 1990). The number of nuclear pores increases throughout the cell cycle, 
but the rate of pore formation is at its highest soon after the cell division, decreasing 
continuously towards the end of the cycle (Maul et al. 1972).  
Finally, it is not known how these changes in cells during the cell cycle affect the 
polyplexes and their ability to deliver genes. 
 
2.5.2 Glycosaminoglycans (GAGs)  
 
GAGs, also called mucopolysaccharides, are highly negatively charged, fairly rigid and 
linear polysaccharides consisting of repeating disaccharides with amino sugars (N-
acetylgalactos-amine/N-acetylglucosamine linked to glucuronic acid). There are several 
major classes of GAGs, including the heparan sulfate (HS), chondroitin sulfate (CS), 
hyaluronic acid (HA) and keratan sulfate (KS) families (Fig. 7). Sulfated GAGs (HS, CS, 
KS) are covalently linked to core proteins forming proteoglycans (PGs) while HA is not 
linked to proteins. HA is a high molecular weight (up to 104 kDa), viscose GAG that endows 
structure and flexibility to the tissue. HA also interacts with lipids and membranes, in water 
and also with itself, leading to aggregation (Scott and Heatly 1999). The size of sulfated 
GAGs is not usually more than 50 kDa. Depending on the cell type and their role in the 
body, variable amounts of GAGs are found within cells, bound to the plasma membrane and 
secreted to the medium.  
The role of GAGs in gene delivery is not yet fully understood. GAGs were previously 
shown to influence nonviral gene delivery: high concentrations of sulfated GAGs in the 
extracellular space (Mislick and Baldeschwieler 1996; Belting and Pettersson 1999a; 
Ruponen et al. 2001) and on the cell surface (Belting and Pettersson 1999b; Ruponen et al. 
2004) decrease or even completely block transgene delivery and expression. However, 
according to some reports, the presence of sulfated GAGs on the cell surface can be 
beneficial for gene delivery (Mislick and Baldeschwieler 1996; Mounkes et al. 1998). High 
concentrations of exogenous HA improve the cellular uptake and the transgene expression 
(Ruponen et al. 2001; Ruponen et al 2004). Some reports demonstrate that the presence of 
sulfated GAGs on the cell surface are beneficial for gene delivery (Mislick and 
Baldeschwieler 1996; Mounkes et al. 1998).  
Changes in GAG synthesis and their secretion throughout the cell cycle have been only 
occasionally studied. It is known that the synthesis of CS, heparan sulfate HS and HA takes 
place during various phases of the cell cycle (Davidson and MacPherson 1975).  Also, the 
synthesis and secretion of the sulfated GAGs have been reported to be reduced or terminated 
during S phase in pig SMC cells, murine melanoma cells and rabbit aorta endothelial cells 
(Blair and Sartorelli 1984; Breton et al.1986 Porcionatto et al. 1998). Furthermore, HS 
synthesis on the cell surface is reduced before mitosis in  synchronized CHO  cells (Kraemer  
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and Tobey 1972). However, it is not known how those cycle-dependent fluctuations in GAGs 
can influence the efficiency of gene transfer. 
 
 
 
 
  
 Hyaluronic acid 
 
 Chondroitin sulfate 
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Figure 7. Chemical structures of disaccharide units in some GAGs (Lodish et al. 2000) 
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3        AIMS OF THE STUDY 
 
The primary objective of this thesis was to study the factors affecting polyplex-mediated 
gene delivery. The following specific questions were posed: 
 
1) Does a polymer structure-biological activity relationship exist for non-viral gene 
carriers? 
 
2) Is PEGylation relevant for complex formation and biological activity? 
 
3)  What is the role of cell cycle phase and cell division in gene delivery? 
 
4) How does the polymer type modify intracellular kinetics and biological activity of 
pDNA complexes during cell division cycle?  
 
5)        Are GAGs relevant during cell division cycle in gene delivery?  
 
6) Are there new efficient gene carriers among the starch-, dendrimer-, glutamate- or  
            methacrylate-based polymer families?  
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4       MATERIALS AND METHODS 
4.1 Plasmids  
The luciferase reporter gene encoding plasmids were driven under the control of CMV 
(pCLuc4; 6.4 kb), (I–III) PDE-β, (II) SV40 and (II) tk (II) promoters. The cloned genes 
were inserted into XhoI-HindIII (pCLuc4, PDE-β, SV40) and BamHI-BglII (tk) sites of 
pGL3-Basic vectors (Reinisalo et al 2003). pCMVß (7.2 kb) (I–III) plasmid encoded ß-
galactosidase. All plasmids were amplified in Escherichia coli (DH5α) and their integrity 
was confirmed by gel electrophoresis. The concentrations of plasmid DNA were determined 
in a UV- spectrophotometer at a wavelength of 260 nm. For the cell uptake study, pCMVß 
was labeled with ethidium monoazide (EMA) by photoactivation as described by Zabner et 
al. (1995) and Ruponen et al. (2001).  Fluorescein-labelled DNA with the β-galactosidase 
reporter gene was a commercially available product (Gene Therapy Systems, Inc. San Diego, 
CA, USA).  
 
4.2 Polymers 
 
Linear poly-L-lysine (I–III) (PLL): mean molecular weights of PLL 2.9 (I), 4 (II), 20 
(I–II), 200 kDa (II–III), PEG20-PLL5 (note: MW of PEG was 20000 and MW of PLL was 
5000), PEG12-PLL5, PEG5-PLL5, PEG20-PLL10, PEG12-PLL10, PEG5-PLL10, PEG20-
PLL20, PEG12-PLL20, PEG5-PLL20 and PLL5-PEG10-PLL5; dendritic PLLs (I): 
PEGylated 3rd, 4th, 5th, 6th  generation and unpegylated (gen.3 and 5) PLLs; grafted PLLs 
(I): PEG5-g-PLL20 (5% grafting density), PEG5-g-PLL20 (10% grafting density) and 
PEG12-g-PLL20 (5% grafting density); branched PLL (I): PLL10 was pegylated with 
PEG5; polyethyleneimines (PEIs) (I-III): mean MW of 25 kDa (II-III), 50 kDa (II), 750 
kDa (II), and 800 kDa (II), fractured sixth generation; polyamidoamine dendrimer 
(PAMAM) (II). Non-PEGylated dendritic PLLs (gen.3 and 5), PEGylated PLLs, and Texas-
Red-tagged PLL 20 kDa (II) and PEI 25 kDa (II) polymers were synthesized in the 
Department of Organic Chemistry, University of Ghent, Belgium.  
 
4.3 Lipids and other materials 
 
Lipids – [1,2-dioleoyloxy-3-(trimethylammoniopropane)] (DOTAP; II), dioleoyl-
phosphatidylethanolamine (DOPE; II), dimethyloctadecylammonium bromide (DDAB; II) 
dipalmitoylphosphatidylethanolamylspermine (DPPES; II), dioctadecylamidoglycyl-
spermine DOGS (II). 
Glycoasaminoglycans (GAGs) (I, III) – Hyaluronic acid (HA) and chondroitin sulfate-
C (CS) were used as 12 mM (I) and 6 mM (I) aqueous solutions, respectively. Heparan 
sulfate (HS)(III) was used as a 90 μM solution.  
Other chemicals – were commercially available and were used without further 
modification. 
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4.4 Physicochemical studies  
 
4.4.1 Complex condensation, stability and binding assays (I)  
 
DNA condensation and stability of the polymer/DNA complexes against polyanions was 
assessed with the ethidium bromide displacement assay (Xu and Szoka 1996). Polymer/DNA 
complexes (0.6µg DNA/well) were prepared in high ionic strength MES-HEPES buffer 
solution at different N:P (+/- ) charge ratios (0.25:1–32:1). DNA binding by polylysines was 
confirmed by gel electrophoresis. The complexes were prepared and loaded with 
bromophenol blue in glycerol into 1 % agarose gel in Tris-Borate-EDTA buffer (TBE) pH 
8.0 and electrophoresed at 60 V, 3 hours. Gels stained with EtBr solution (0.5 mg/l) were 
transilluminated on a UV-light to localize the DNA.  
 
4.4.2 Complex size and electrical properties (I)  
 
For the size distribution measurements, polymer/DNA complexes were prepared in high 
ionic strength MES-HEPES buffer at charge ratio 2:1 by adding diluted polymer into DNA 
solution (20 µg/ml DNA)  obtaining a final sample volume of 2 ml. The scattered light of the 
complexes were measured at the wavelength of 488 nm (DLS-700, Otsuka, Japan). For ζ-
potential measurements, polymer/DNA complexes were prepared in water at charge ratios 
0.5:1 - 4:1 obtaining a final sample volume of 2 ml (20 µg/ml DNA). ζ-potentials were 
measured at the wavelength of 632.8 nm (NICOMP™ zetapotential/particle sizer 380 ZLS, 
Santa Barbara, CA, USA). 
 
4.4.3 Complex morphology (I)   
 
Complexes of DNA with PLL G3 (dendrimer), PLL 20 (linear), PEG-PLL G5 
(dendrimer), PEG5-PLL20 (linear) and PEG5-g-PLL20 (5% grafted) polymers were chosen 
for the morphological study. Polymer/DNA complexes of +/- charge ratio 4:1 were placed on 
carbon-coated grid and negatively stained with a droplet of 2 % uranyl acetate (aqueous 
solution, pH 4.5) for 2 min. The samples were analyzed under transmission electron 
microscope (TEM) (JEOL JEM-1200 EX, Japan).  
 
4.5 Biological studies  
       
4.5.1 Synchronization of cells (I–III)  
 
Cells were arrested in the early G1 phase by incubation in the growth medium with a 
reduced serum concentration (0.1 % FBS) for 72 h. Synchronization of D407 cells to the 
G1/S phase boundary was performed with the double thymidine blocking procedure (Stein et 
al.). Cells  were  first  cultured  in  growth  medium  containing  2 mM  thymidine  for  16 h,  
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followed by culturing for 9 h with growth medium containing 24 µM deoxycytidine and, 
then finally, for additional 16 h with 2 mM thymidine in the growth medium. In order to 
reach G2/M phase, the cells were grown in the culture medium for another 9 hours after the 
removal of the second thymidine block. Flow cytometric analysis of D407 cells showed that 
both G1 and S phases lasted for about 9 h, whereas the G2/M phase was 3 h.  
 
4.5.2 Cellular uptake studies (I–III) 
 
One day before transfection, the cells were seeded on plates for the cellular uptake study 
of non-synchronized cells (I). The complexes were prepared by adding polymer solution on 
the EMA-labelled DNA (6.7 µg) to obtain optimal polymer/DNA (+/-) charge ratios of 4:1 
(PLL 20 kDa). Synchronized cells (II) were transfected with 4 µg of EMA-labelled DNA at 
optimal polymer/DNA (+/-) charge ratios of 4:1 (PEI25 kDa) and 2.4:1 (PLL 200 kDa). For 
fluid-phase endocytosis experiments (III), cells were arrested to early (G, S) and middle (G, 
S) subphases, and G2/M phase of the cell cycle and exposed to fluorescein-labeled (FITC) 
dextran (anionic, MW 10 kDa) with concentrations of 21.5 μg/ml and 50 µg/ml at different 
time points (20 min, 60 min, 180 min). After 5 hours exposure to the complexes or FITC-
dextran, the fluorescent cells were analyzed. Cells were fixed in 1 ml of 1 % 
paraformaldehyde, and analyzed with a flow cytometer (Becton Dickinson FACScan, San 
Jose, CA, USA). From each sample, 10 000 events were collected and fluorescence detected 
using a 525 nm (FITC) or 630 nm (EMA) filter. The background autofluorescence of the 
cells and complexes was excluded by using unlabelled DNA polyplexes as controls.  
.        
4.5.3 Transfection experiments (I-III) and cytotoxicity (I) 
 
Non-synchronized (I) retinal pigment epithelial cells (D407), were seeded into wells one 
day before transfection. Polymer/DNA complexes were prepared in high ionic strength 50 
mM MES-50 mM HEPES-75 mM NaCl buffer at different charge ratios by adding polymer 
solution on DNA (1.8 µg), incubated for 15–30 min and added on cells in serum-free media 
for 5 hours. The amount of reporter gene was analyzed 43 hours later. Reporter genes were 
delivered into synchronized (II–III) cells – stably and non-stably expressing luciferase – in 
plasmids with a variety of promoters controlling expression of either luciferase (pCLuc4, 
SV40-luc, tk-luc, PDE-β-luc) or ß-galactosidase (pCMVβ). Cells were seeded on 6-well 
plates 24–72 h before transfection, synchronized and grown in the culture medium for 3 or 9 
hours until middle subphase (G1 and S phases) or G2/M phase was reached. Complexes with 
optimal charge ratios of +/- 4 (PEI 25 kDa:DNA) and +/- 2.4 (PLL 200 kDa:DNA) were 
formed in MES-HEPES buffered saline (4 µg DNA) and incubated with cells for 3 h. After 
removal of the complexes, the cells were washed with PBS buffer and incubated for an 
additional 20–43 h in complete medium. The cell lysate was assayed for the β-galactosidase 
or luciferase activity and protein content.  
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The cytotoxicity of the polymers was tested using colorimetric MTT assay. Cells were 
seeded on plates one day before transfection, and then 0.6 µg of DNA complexed with 
polyplexes were added on the cells in the serum-free medium for 5 hours, and cell viability 
was analyzed after 43 hours of incubation 
        
4.5.4 Localization of pDNA (II-III) 
 
For visualization, localization and quantification of the DNA and the complexes by 
confocal microscopy (II), D407 cells were plated on 8-coverglass chambers, synchronized as 
described earlier, and transiently transfected in the middle phases with fluorescently (FITC-
labelled) DNA. Carriers PEI and PLL were labelled with Texas-Red. After 1 h transfection 
and 3 h in serum-containing medium living cells were studied under a confocal microscope 
(Perkin Elmer-Wallac-LSR, Oxford, UK). The images of green (FITC) and red (Texas-Red) 
fluorescence were collected separately and combined as a RGB image representing the 
middle section of 10 optical slices. IpLab software (Scanalytics, Fairfax, VA, USA) was 
used for image-analysis. Positive particles having the area of one pixel were omitted from 
the analysis. Finally, integrated positive signal area of red and green fluorescence, and their 
co-localization ratio were calculated for each cell and nucleus areas. PCR experiments (III) 
were performed for quantification of the free/loosely complexed cytoplasmic and nuclear 
pDNA. Nuclei of the cells, detached with trypsin/EDTA were isolated 20 h post-transfection 
by repeated centrifugations in lysis and wash buffers. Nuclear, cytoplasmic and PCR-
mixture was set up in 96-well reaction plates and diluted samples in 5 μl of sterile water 
were added (total volume 15 μl). In order to quantitate the total amount of pDNA in the 
nucleus, the complexes were disrupted by HS treatment prior to PCR amplification.  
 
4.5.5 Analysis of GAGs (III)  
 
D407 cells were arrested at different phases of the cell cycle with reduced serum or 
thymidine block and double-labeled by incubating with [3H]-glucosamine and [35S]-sulfate. 
Medium, supernatant (trypsin) and the cell pellets were collected separately for isolation of 
the GAGs. Radiolabeled GAGs were purified with cysteine-EDTA or sodium acetate-
cysteine-EDTA solutions followed by papain endopeptidase, cetylpyridinium and ethanol 
treatments. Samples were incubated overnight with 25 mU chondroitinase ABC, 1 mU 
hyaluronidase and 0.5 M ammonium acetate (pH 7.0) at 37 °C and quantified as 
disaccharides on the following day by gel filtration. HA control was used to monitor the 
recovery and to calculate corrections for any losses in purification process. Quantification of 
GAGs was based on the calculated specific activity of [3H]-glucosamine (HS, HA) and the 
measured specific activity of [35S]-sulfate (CS) (Yanagishita1989; Tammi 2000). 
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4.5.6 Statistical analysis (II)  
 
The statistical significances of the transfection difference between cell cycle phases and 
between polyplexes were tested by unpaired t-test (II). Differences between cell cycle phases 
for transgene uptake, luciferase expression and GAGs were tested with Mann Whitney´s U-
test (II–III). 
 
4.6 Additional studies with various polyplexes  
 
Transfection and cytotoxicity studies were carried out with various polymers to discover 
their efficiency in gene delivery. Modified starches (pure amylose, amylose-rich and pure 
amylopectin), starburst dendrimers (PEGylated, histidylated, oleylated, lysinated), poly-L-
glutamic acids (PEGylated block-co-polymers, pyridine, carboxylic acid and imidazole as 
functional groups) and polymethacrylates (pyridine, carboxylic acid and imidazole as 
functional groups). pDNA binding and polyplex size were investigated with most of the 
polymeric carriers. The cellular uptake study evaluated by flow cytometer was carried out 
with some of the derivatives of the starch carrier. DTAF (5-(4,6-dichlorotriazinyl) 
aminofluorescein) labelled starch was complexed with pDNA (0.5 µg), and thereafter 3 x 104 
cells of the D407 cell line were exposed to the complexes for 1–24 h and analyzed for 
cellular uptake of polyplexes by confocal microscopy. Starch derivatives were synthesized 
by Raisio Chemicals Oy, Finland and VTT Processes, Finland. Starburst dendrimers, poly-L-
glutamic acids and polymethacrylates were synthesized in the Department of Organic 
Chemistry, University of Ghent, Belgium.  
      Lipid-coating was prepared onto PEI 25 kDa/pDNA polyplexes in order to study the 
mechanism of cellular uptake and intracellular distribution of polyplexes. Diolein (DO), 
cholesteryl hemisuccinate (CHEMS) and oleic acid (OA) were purchased from Sigma and 
DOPE from Avanti Polar Lipids. Diolein/CHEMS or OA/DOPE in chloroform was used at a 
lipid ratio of 2:1. After evaporation of chloroform, the lipid films were dissolved in a 
surfactant octylglucoside (Sigma). The coating was formed when PEI/pDNA complexes 
were added step-wise into the lipid mixture and diluted drop-by-drop with 10 mM HEPES 
buffer below the solubility ratio of octylglycoside/lipid, 2.62 (molar ratio). Finally, the 
formed complexes were dialysed overnight against 10 mM HEPES buffer and the sizes of 
the complexes were measured. 
The strength of the lipid-coating against anionic dextran sulfate was assessed with the 
EtBr binding assay with slight modifications to the protocol presented above. EtBr can bind 
and fluorescence only when intercalated between the strands of the DNA double helix, 
therefore, the recovery of fluorescence after addition of anionic dextran sulfate (0.5 mM) 
into the solution of complexes (0.6 µg/well) and EtBr (0.3 µg/well) reflects the degradation 
of lipid-coating. Triton-X 100 (10 %) was used to degrade the lipid-coating, thereby 
allowing dextran sulfate to relax the complexes in order to reveal the amount of pDNA 
encapsulated within the lipid-coat.  
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5       RESULTS 
 
5.1 Effects of polymer structure on complex formation 
 
5.1.1 Shape and size  
 
At low +/- charge ratios, almost all linear 5-20 kDa PLLs condensed DNA more 
efficiently (1:1) than dendritic PLLs (2:1–8:1) (I: Fig. 2) but increasing the mount of 
primary amines at the surface of dendritic PLL improved DNA binding (non-PEGylated: 8 
NH2 G3 vs. 32 NH2 G5, PEGylated: 8 NH2 G3 vs. 64 NH2 G6). Similarly, the 14 lysine 
residues in a linear PLL 2.9 kDa (non-PEGylated) molecule are not able to bind DNA 
efficiently at charge ratios near to neutrality, unlike the 95 lysine residues in a linear PLL 20 
kDa (non-PEGylated). These experiments showed that also grafted and branched polymer 
shapes of PLL (PEGylated) bound DNA completely at a charge ratio of 1:1. Although DNA 
binding and condensation by the linear and dendritic PLLs were different, this was not 
usually seen as different complex size distributions. In the case of non-PEGylated PLLs, this 
is due to the aggregation of the complexes by both PLLs. There was one exception, the 
PEGylated dendritic PLL (G3) gave a large complex size compared with the other shapes 
due to its poor ability to condense DNA. In addition, there were no large differences in the 
complex surface charge (ζ-potential) among the various molecular shapes.  
TEM studies were carried out to characterize the morphology of the complexes. The 
shape of the polymer itself had no effect on the morphology of the complexes. PEGylated 
PLLs exhibited a similar rod or toroid form irrespective of the polymer shape. Instead, non-
PEGylated dendrimer and linear PLLs revealed different morphologies most probably 
arising from differences in their ability to condense DNA. Linear PLL produced aggregates 
of spherical complexes, thus, the actual morphology of the complexes was not evaluated. 
Third generation dendritic PLL that showed poor DNA binding and condensing, formed 
loose toroids (I: Fig.3A) and some rods, that appeared to be trapped in a net of DNA strands. 
  
5.1.2 PEGylation  
 
PLLs were modified in a variety of ways with PEG in this study. Linear PLL was 
converted to diblock (PEG-PLL), triblock (PLL-PEG-PLL) and grafted (5 or 10%) 
copolymers. Also, PEGylated dendritic and branched PLLs were generated and tested. 
PEGylation improved binding and condensation of DNA only in the case of dendritic 
PLL G5 (I: Fig 2.). The PEGylated 3rd generation PLL did not have enough primary amines 
on its surface, leading to poor binding of DNA. Most of the PEGylated PLLs were as 
efficient with respect to DNA binding as linear non-PEGylated PLL, but DNA condensation 
was most efficient when the fraction of PEG was about 60 % or less of the PLL MW (I: 
Fig.7). PEGylation of PLLs had a clear effect on the size distribution of polyplexes. The size 
range  of  all  PEGylated  complexes  was  27–123 nm. Despite  the  high  ionic  strength  of   
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MES-HEPES with 75 mM NaCl, the PEGylated complexes retained low polydispersities and 
small complex sizes, in contrast to the non-PEGylated complexes. PEGylation decreased the 
electrical surface charge of the complexes at positive +/- ratios, but the ζ-potentials were still 
positive (+3 – +23 mV). There was one exception, samples of pegylated G3 PLL 
dendrimer/DNA showed negative ζ-potential even at a 4:1 ratio, due to the poor DNA 
binding by this polymer. 
Microscopy results were in line with the size determinations. While complexes of non-
PEGylated linear PLL showed highly condensed but aggregated particles, the PEGylated 
linear, grafted and dendritic (G5) polymers formed separate rods upon complexation with 
DNA (I: Fig.3 C-E). The size range of the toroidal and rod-like complexes varied from 50 to 
250 nm. In addition, the dendritic non-PEGylated PLL (G3) revealed some loose toroid-like 
structures with diameters of about 150–200 nm and rods about 300–450 nm of length, 
although they were not separate from the net of the DNA. However, PEGylation of PLL 
seemed to have a favourable impact on the formation of toroid and rod-shape complexes.  
5.2 Factors affecting biological activity of polyplexes 
 
5.2.1 Polymer structure 
 
Type – In general, the transfection efficiency of non-PEGylated PLLs is lower than some 
other transfection carriers, such as PEI 25 kDa and DOTAP (II: Fig. 2). However, the flow 
cytometric (FACS) study revealed a similar efficiency in cellular uptake of PEI 25 kDa and 
PLL 200 kDa polyplexes showing internalized pDNA in ~ 80 % of the cells. Despite the 
similar efficiency in cellular uptake, more pDNA was accumulated in the nucleus of the PLL 
treated (1.2 to 3.5-fold) than the PEI treated cells. This was not reflected in the luciferase 
transgene expression, however, since PEI-treated cells expressed 3–55 times higher levels of 
luciferase than PLL-treated cells (III: Fig. 2). PLL polyplexes also showed less variation in 
luciferase expression compared to PEI polyplexes throughout the cell cycle showing nearly 
constant expression, while PEI revealed an increasing trend (III: Fig. 2). Expression 
efficiency (i.e. ratio between luciferase expression and nuclear pDNA) of PEI polyplexes was 
~10–100 times that of PLL polyplexes (III: Fig. 3). 
      Shape – At a charge ratio 4:1, linear unmodified PLL 20 kDa polyplexes were taken up 
by the cells efficiently (> 60% positive cells; I: Fig. 6).  It is also a better transfection agent 
than dendritic PLL or linear PLL 2.9 kDa. PEGylated linear or grafted PLLs carried pDNA 
into the cells more efficiently than PEGylated branched and dendritic PLLs (>70 % vs. < 40 
%; I: Fig. 6). However, in general, the transfection ability of PLL 20 kDa was very limited, 
therefore, linear PLL 200 kDa was selected for further studies.   
  PEGylation – PEGylation of PLL20 increased slightly (up to 90 %) the cellular uptake 
of linear PLL 20 polyplexes at the optimal charge ratio of 4:1 (I: Fig. 6), and also improved 
the transfection efficiency (Fig. 5). The most efficient carrier was linear PEG5-PLL20 and 
triblock  (PLL5-PEG10-PLL5)  was  less  efficient  than  most  of  the  diblock polymers. All  
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PEGylated  dendritic  PLLs  showed  lower  transfection  activities than their linear, grafted 
or branched counterparts. PEGylated branched and grafted PLLs transfected to a similar 
extent as the linear PLLs (I: Fig. 5A-B).  
 
5.2.2 Cell cycle phase 
 
The results of the pinocytosis study (fluid-phase endocytosis) (III: Fig. 5) with dextran 
molecules and experiments with D407 6-2 cell line cells having stably integrated luciferase 
gene (II: Fig. 9) support the findings of the cellular uptake (II: Fig. 4) and transfection 
studies (II: Figs. 5-6; III: Fig.2) with the polyplexes. The cellular uptake of dextran was at 
its lowest in the cells in the G1 phase and the integrated transgene expressed about twice 
more luciferase in the cells in the G1 phase than cells in the S or G2/M phases. Therefore, 
the cell cycle phase is clearly a major determinant of gene delivery.  
 Cell cycle-related experiments can be performed only if the total lengths of the cell cycle 
phases G1, S, and G2/M phases are known. The determination of the lengths of these phases 
in D407 cells was carried out by treatments with 0.1% serum (G1 phase) and double 
thymidine block (S and G2/M phases) and by analysis with the flow cytometer based on the 
amount of DNA in the cells. The lengths of the phases were about 10, 9, and 3 h, 
respectively.  
 
Promoter – Different promoters may be differentially sensitive to the cell cycle possibly 
due to the presence of distinct binding sites for various transcription factors. This was 
assessed by studying transfections with several promoters driving the expression of 
luciferase.  The results showed that strong viral promoters CMV and SV40, and also tk 
promoter were more effective in gene transfer than PDE-β (II: Figs. 6A-B) and the levels of 
gene expression were always cell cycle-dependent. PEI-mediated transfections exhibited 
high sensitivity to the cell cycle, especially between G1 and S phases. Furthermore, all 
promoters were affected by the cell cycle in a similar way with PLL complexes, but the 
differences were not always significant and the levels of tranfection were low. These results 
demonstrate that the effect of the cell cycle phase on transfection efficiency is more 
pronounced with PEI polyplexes than with PLL polyplexes, and it is not limited only to the 
CMV promoter.  
 
Cellular uptake and intracellular distribution of DNA – The flow cytometric results 
demonstrated high cellular uptake of polyplexes (~ 80 %) during phases other than G1 phase 
(~ 5–30 %) (II: Fig. 4). In this experiment, only the free and/or loosely complexed pDNA 
which is presumably directly accessible to the transcription machinery were quantified. After 
polyplex treatments, G1 phase cells contained ~8–20 pDNA copies per nucleus (III: Fig. 2) 
being at S phase ~ 4 to 5-fold and G2/M phase ~ 10 to 20-fold more than in the G1 phase 
cells. PLL treated cells contained up to 3.5 times more nuclear pDNA available for PCR 
amplification  than  the  corresponding  PEI  treated cells (G2/M<G1<S). The majority of the  
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internalized pDNA remained in the cytoplasm (III: Fig. 2), but the fraction that ended up in 
the nucleus increased when the cells went from G1 through S to the G2/M phase (from 0.3 % 
to >8 %, G1<S<G2/M). However, these figures overestimate to some extent the fraction, 
since most likely a part of the administered pDNA was degraded in the cytoplasm during the 
20 h between transfection and isolation. HS was used to completely disrupt the polyplexes 
for determination of the total pDNA content in the nuclear fraction. This indicated a ~2–265 
times increase (PEI>PLL) in the pDNA content (data not shown).  
 Visualization of the complexes in the confocal microscope revealed similar results as 
obtained in the PCR experiments: the plasmid-DNA appeared mostly in the cytoplasm and 
mainly in the complexed form (II: Fig. 7A–C). Typically, cells contained only small 
amounts of polyplexes, but some cells, especially at S phase, contained substantial amounts 
of complexes and the free carrier. A total of 180 cells transfected with PEI 25 kDa were 
analyzed but only the cells containing plasmid-DNA were included: 21 (G2/M), 16 (G1), 
and 25 (S) cells. The cells were divided into three groups mainly based on the number of 
nucleoli (II: Fig. 7A–C). The nucleolus is the most visible nuclear structure and it changes 
during the cell cycle, reflecting its transcriptional activity (Bloom and Fawcett 1975; Alberts 
et al 1994b). Before mitosis, the nucleolus decreases in size and then disappears. After 
mitosis, tiny nucleoli reappear and during G1, S and G2 phases they fuse to form one large 
nucleolus. However, not only changes in the nucleolus were evaluated, also the shape of a 
cell, the size of the nucleus and the synchronization method were taken into account when 
assessing the phase of a cell. Also, quantitation of pDNA by image-analysis revealed the 
same results as the PCR experiments (II: Figs. 8A–B), although quantification with PCR 
was more precise. The cells had accumulated up to 6.5 times less DNA into the nucleus than 
was present in the cytoplasm.  
Interestingly, there was free DNA in the cytoplasm only in the G1 group cells. 
Furthermore, microscopic examination revealed a similar trend, with free DNA in the 
nucleus as was noted by PCR with respect to nuclear-pDNA: the amount of pDNA increased 
steadily throughout the cell cycle.  
 
Transgene expression – The level of transgene expression depends strongly on the 
polyplex-type used but also the cell cycle phase. The highest expressions were seen either in 
the cells in the S (analyzed 43 h post-transfection, II: Figs. 6A–B) or G2/M (20 h post-
transfection, III: Fig. 2) phases in comparison with the low expression levels at the G1 
phase. Although the expression level of the luciferase reporter gene is modified by the cell 
cycle, it exhibits a non-linear relationship with the nuclear pDNA (III: Fig. 2). A poor 
correlation was particularly evident in the cells transfected with PLL, and a better, but still 
non-linear relationship with PEI transfection. We also used D407 6-2 cells that stably 
express tetracycline-repressible luciferase (Antopolsky et al. 1999) to examine whether the 
effects of the cell cycle effects on transgene expression were due to: i) cell cycle-depedent 
differences in  transcription and translation or ii) DNA delivery into the nucleus in an    
active form.  Synchronized  cells  were  exposed  to  polymer/pCMVβ  complexes  and non- 
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synchronized cells were used as controls. Although the effect appeared to be mild, the 
expression levels of endogenous luciferase under CMV promoter both with and without 
polyplex treatment were decreased during the G1 phase (II: Fig. 9). Without administration 
of polyplexes, luciferase  expression  was  about  1.3 times higher in the S phase compared 
to the G1 phase. After polyplex treatment, stable luciferase was expressed about 1.8–2.3 
times more in the S and G2/M phases than in the G1 phase (P<0.05; Fig. 9).         
 
5.3  GAGs in gene delivery  
 
5.3.1   Exogenous GAGs 
 
Lipoplexes and polyplexes may react with GAGs leading to DNA release from the 
complexes or relaxation of the complexes (Xu and Szoka 1996), thereby affecting 
transfection. When GAGs are added to the complexes, some of the fluorescence of the EtBr 
bound to DNA may recover due to the displacement of the carrier or to changes of the 
complex conformation. In our experiments, anionic HA did not relax the complexes of linear 
or dendritic PLL at any +/- charge ratio (data not shown), while CS-C could recover 10–15 
% of the fluorescence at charge ratios above 1:1 (I: Fig. 4). 
 
5.3.2   Endogenous GAGs 
 
Differences in GAG profiles were investigated as one possible explanation for cell cycle-
dependent gene transfer. The GAGs expressed by D407 cells on their cell surface, in 
intracellular compartments and secreted into the medium were predominantly sulfated GAGs 
(>85 %; III: Table1). HA was expressed to a lesser extent (<15 %). The cell surface (>56 %) 
and the medium fractions (> 59 %) were dominated by CS whereas HS was the main 
intracellular GAG (54–59 %). The largest quantities (~ 500–3400 amol/cell) and the greatest 
variations of GAG concentrations were seen in the secreted fraction (Table 1). Cells in the 
G1 phase secreted about 5–40 times larger quantities of each GAG than cells in the S and 
G2/M phases (III: Table 1). Relatively small differences were noted in the secretion of the 
GAGs between the cells in the S and G2/M phases. Assuming a typical chain size of 30 kDa 
(≈ 50 disaccharides, length 50 nm) (Yanagishita and Hascall, 1992) for HS and CS, the 
surface of these cells were covered by around 2-5 ×106 sulfated GAG chains, while the 
higher average size of HA (2000 kDa) (≈ 5000 disaccharides, 5 μm) (Ruponen et al. 2004) 
suggested 1–4 ×103 cell surface chains (III: Table 1).  
 
 
 
 
 
 
 
 
 46
 
5.4  Additional studies with various polyplexes 
 
 
We also studied other polymers in addition to PEI 25 kDa and PLL 200 kDa for gene 
delivery purposes. We found that pure amylose or amylose-rich starch (~70 %) bound pDNA 
totally mainly at charge ratios of 1:1, but sometimes at 2:1, while pure amylopectin bound at 
a charge ratio of 8:1 or not at all. Pure amylose can produce polyplexes of ~ 30–150 nm size, 
but when combined together with amylopectin, the sizes can increase to ~ 45–400 nm. The 
degree of substitution (DS) varied between 0.17–1.1 in this study. The experiments to 
determine the effect of MW on the size distribution exhibited an inverse relationship 
between MW of the carrier and polyplex size at charge ratios above 2:1 (Fig. 8). The 
polyplex size is also dependent on the charge ratio. Acetylated amylose-rich starch 
(acetylation DS 0.3–2.8, cationization DS 0.07–0.3) bound pDNA totally at charge ratios of 
1:1 but the complex size was mainly above 1µm. Cationic inulines (DS 0.37–1.23) bound 
pDNA totally at charge ratios of 2:1 and 1:1 depending on the DS, but they formed 
polyplexes with high dispersities (<100 nm to 1-2µm). Diethyaminoethylethers of starch 
bound pDNA efficiently, but carboxy methyl cellulose derivatives of starch were inefficient 
at binding pDNA. 
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Figure 8. The effect of MW on size distribution with pure amylose carrier/pDNA complexes. Degree of 
polymeration (DP) varied between 10 and ~230 and DS varied between 0.1–0.55. The increase in MW 
was ~10 kDa being ~50 kDa between the smallest and largest molecules.    
              
                                     
Polyplexes with pure amylose or amylose-rich carriers exhibited ~ 40–60 % cellular 
uptake even at a charge ratio of 1.5:1 when DS was > 0.5. The confocal microscopic pictures 
support the cellular uptake study, but they also suggest that although carrier, pDNA and the 
complexes are for the most part localized near to the cell membrane (Figs. 9B–D), they are 
also present in the nucleus, but mainly in a complexed form (Fig. 9E). Transfection studies 
with starch/pDNA polyplexes resulted in no transgene expression in D407 cell line cells in 
comparison with PEI 25 kDa or PLL 200 kDa, but also toxicity was low (< 25 %). 
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Figure 9. Confocal microscopy images of D407 cell line cells after 24 hour (A–D) and 3 h (E) of 
exposure to the amylose starch/pDNA polyplexes. (A) Localization of DTAF-labelled starch carrier (DS 
0.52, Mw 185 kDa). (B) Localization of rhodamin-labelled pDNA. (C) Combination image of the images 
A and B, yellow color shows the localization of the carrier/pDNA complexes. (D–E) Combination of the 
confocal and light microcopic images showing the localization of polyplexes within the cells. (F) Image of 
the polyplexes without cells.  
 
We also investigated structural-activity relationships of different modifications of 
Starburst dendrimers (SB) (Gen. 3-4). We found that all of the studied modifications bound 
totally pDNA at a charge ratio 1:1 but PEGylated SB formed smaller complexes (mainly 
<250 nm) than lysine and oleoyl modifications (nearly 1µm). The transfection efficiency 
remained low with carriers other than lysine coated SB in comparison with PEI 25 kDa 
(~3.5–10 times less), although the efficient charge ratios with SB lysine were relatively high 
(Fig. 10).  Cytotoxicity was mainly found to be < 30 %.  
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Figure 10. Transfection efficiencies of SB derivatives in D 407 cell line cells at different polymer/pDNA 
charge ratios (32:1–1:1). Charge ratios of PEI 25 kDa were between 36:1–1.1. 
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 variety of MW of poly-L-glutamic acid (PDMAEG) block-co-polymers with PEG or 
pyr
coated PEI 25 kDa/pDNA polyplexes with diolein/CHEMS 
(DO
 
 
100% represents the completely relaxed/free DNA in solution. 
A
idine, carboxylic acid and histidine as functional groups were tested but they displayed no 
efficiency in comparison with PEI in gene delivery into D407 cell line cells. However, some 
differences between PDMAEG derivatives have been seen with cells of the 293 cell line 
(Dekie et al. 2000). The toxicity of these polymers was 10–15 % in D407 cells and 15–20 % 
with EA.hy 926 (Human-derived endothelial cell line) (Dubruel et al. 2003b). 
Polymethacrylate derivatives (PDMAEMA) bound totally pDNA at a charge ratio of 1:1. 
Although they were not as efficient in gene delivery into D407 cells as PEI 25 kDa, they did 
exhibit some efficiency, which was related to the functional group in the polymer structure. 
Derivatives with pyridine showed an efficiency which was nearly half of the efficiency of 
PEI, while carboxylic acid and imidazole derivatives displayed no efficiency at all. 
Similarly, carboxylic acid and imidazole derivatives have not been able to transfect other cell 
lines, e.g. COS-1 cells (Dubruel et al. 2003a). PDMAEMA derivatives showed cytotoxicity 
which was less than 30 %.  
Finally, we prepared 
/CHEMS) or oleic acid/DOPE (OA/DOPE) at charge ratios of 4:1–16:1 in order to study 
the mechanism of cellular uptake and distribution of polyplexes within cells. The EtBr 
displacement –assay showed that coating resisted relatively well the addition of dextran 
sulfate, thereby protecting the complexes from the anionic polymer and preventing the 
release of pDNA (Fig.11). After 1 h, ~5–8 % and at 24h ~25–50 % of the fluorescence was 
recovered with the diolein/CHEMS-coated polyplexes. Correspondingly, 17 % and 43 % 
recoveries were observed after 1 h and 24 h exposure with OA/DOPE-coated polyplexes. 
The difference to uncoated PEI polyplexes was conspicuous (Fig. 11). The agarose gel –
experiment supported the result of the EtBr assay showing that pDNA was not released from 
the complexes after addition of dextran sulfate. We also transfected different cell lines with 
the coated polyplexes but precipitation of the complexes in the wells remained a problem. 
Figure 11. The effect of dextran sulfate on DO/CHEM-coated PEI 25 kDa/pDNA polyplexes at charge
ratios of 4:1–16:1. C and UC stand for coated and uncoated complexes, respectively. Fluorescence of
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6        DISCUSSION       
 
6.1 Polymeric gene delivery systems   
 gene delivery – The dendritic shape and the small 
mount of primary amines on the surface of PLL G3 and PLL G5 molecules, 8 and 32, 
res
ith 
CS
l complexes. This is in line with the more efficient DNA condensation by linear than  
 
 
Physicochemical properties affecting
a
pectively, are not optimal for pDNA binding. In addition, the orientation of the amines 
may not be favourable, since pDNA is not flexible enough to wrap around the small PLL G3 
molecules, and therefore, some positive charges are not reached by the phosphates of pDNA. 
Linear PLL 20 kDa contains about three times more primary amines than the G5 dendrimer 
and due to its long and more flexible structure, its amines are more readily accessible to the 
phosphates of DNA. The disadvantage of the dendritic shape has also been observed with 
geometrically differing lipopolyamines (DOGS as a starting material) on HeLa cells (Byk et 
al. 1998). A linear shape of lipopolyamines is the most efficient in terms of transgene 
expression, followed by a branched shape, whereas the globular shape results in the lowest 
activity. Previously, PAMAM dendrimers have been shown to be very active transfection 
agents (Haensler and Szoka 1993; Tang et al. 1996; Ruponen et al. 2001; Urtti et al. 2000), 
with fractured dendrimers being more effective than intact spherical dendrimers (Tang and 
Szoka 1997). Furthermore, branched and flexible PEI 25 kDa and linear PLL 200 kDa 
plasmid carriers are not only structurally very different, but they also have different 
buffering capacities at endosomal pH range (5.5–7.4) (Tang and Szoka 1997). PEI with its 
good buffering capacity, can destabilize endosomal and lysosomal membranes (Klemm et al 
1998; Godbey et al 1999), thereby facilitating the release of the complex from 
endolysosomal vesicles. PEI is clearly a better transfection agent than linear unmodified 
PLL, which has a poor buffering capacity at pH < 8. Therefore, apparently, the shape of the 
polymer alone is not the crucial factor in DNA condensation and efficient gene delivery.  
PEGylation provided sterical stabilization and a small size to the PLL polyplexes, but 
only partial shielding, which was not able to protect the complexes from interactions w
-C. The amount of PEG may be insufficient or PEG may become poorly oriented (not 
always on the surface of polyplex). These results also suggest that PEGylated complexes 
may react with the cell surface proteoglycans (i.e. CS or HS), and in that way transfer the 
associated GAGs into the cells, as previously described for non-PEGylated PLL (Ruponen et 
al. 2001). The effect of PEGylation on transfection by other carriers is not straightforward. 
Ross and Hui (1999) reported enhanced lipoplex-cell association and lipofection with many 
different cell lines in the presence of PEG in the transfection media. Also, Toncheva et al. 
(1998) and Choi et al. (1999) reported enhanced polyfection after incorporation of PEG onto 
PLL, whereas transfection efficiency has been reported decline after PEGylation of amine 
methacrylates (Rungsardthong et al. 2001) and PEI (Nguyen et al. 2000; Erbacher et al. 
1999). 
     Linear PLL 20 showed no rod-like or toroidal complexes, but rather aggregates of 
spherica
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dendritic PLL (20 kDa). Clearly, also non-PEGylated PLLs (G3) are trying to form 
complexes with a defined structure, but it appears that the 8 primary amines on the polymer 
rface are not enough to condense DNA properly. It seems that the final particle size of 
ay due to several reasons: i) improved cellular uptake of the polyplexes 
rovides more polyplexes that may be available for nuclear uptake. In addition, ii) PEG is 
kno
f the administered pDNA (~10–20 
pg
su
PLL polyplexes, at least in high ionic strength solution, is determined by aggregation rather 
than condensation of pDNA in single particles. Even though non-PEGylated PLL condenses 
DNA efficiently, these complexes may aggregate, unlike PEGylated condensates which form 
toroidal complexes. This is line with earlier reports on PEGylation (Tonceva et al 1998; 
Seymour et al 1998; Kwoh 1999, Rungsardthong et al. 2001). Apparently the size 
distribution, ζ-potential and DNA binding results with dendritic PLL G3 polyplexes are a 
consequence of combinations of the polyplexes and the associated net of uncondensed DNA. 
Probably, linear and grafted PLL molecules are more flexible than their dendritic 
counterparts, and therefore, the negative charges of DNA can bind to the cationic charges in 
spite of PEG. 
 
Effects on biological activity – The improved transgene expression of PLL 20 kDa upon 
PEGylation m
p
wn to induce association and fusion of phospholipid vesicles at high concentrations 
(Yamazaki et al. 1990). Therefore, surface-oriented PEG molecules on the polyplexes may 
induce leakage of endosomal membranes resulting in improved cytoplasmic release of DNA 
or complexes. On the other hand, iii) electrically neutral PEG molecules might improve the 
diffusivity of the polyplexes in the cytoplasm. However, the validity of these mechanisms 
still awaits verification. Despite the improvement of transgene expression by PEGylation, 
the efficiency with PLL 20 kDa was extremely limited. Also, the efficiency of PLL 200 kDa 
was restricted, but clearly higher than with PLL 20 kDa 
 The cellular uptake of PEI 25 kDa and unmodified PLL 200 kDa polyplexes differs only 
in the cells at the G1 phase, 30 and 5 %, respectively. Although cellular uptake of pDNA is 
relatively high (up to ~85 %), only 10-6 – 10-4 parts o
/cell) accumulated into the nucleus of D407 cells and was available for PCR amplification. 
Here, we quantified only the free or complexed pDNA, which was in a loose enough state to 
permit PCR amplification, and presumably also for transcription, thus, reflecting a 
“therapeutic” situation. However, there is a significantly higher amount of the transgene in 
the nucleus, but most of this pDNA is still bound and cannot be amplified by PCR. Bound 
nuclear pDNA may result from its delivery in a complexed form or from its re-complexation 
in the nucleus by the cationic carrier and/or by the histones. The fact that we observed more 
pDNA in the nuclei of cells exposed to PLL polyplexes (< 3.5-fold), but luciferase reporter 
gene was expressed more with cells exposed to PEI polyplexes (< 55-fold), suggests that the 
difference in transgene expression between PEI and PLL polyplexes may also arise from 
differences in the nuclear transcription efficiency. We found that PEI possesses ~ 10 to 100-
fold better (G1<G2/M<S) expression efficiencies in comparison with PLL. The non-linear 
correlation  between  the  amount  of   nuclear   pDNA   and  luciferase  expression  with  the  
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polyplexes is not clear but has also been noted previously with lipoplexes (Hama et al. 2005; 
Morguchi et al. 2006). 
 
r uptake of the complexes is low when most of the cells are in the G1 phase and 
ycle phase restricts the gene 
elivery. Similarly, nuclear uptake, transgene expression and expression efficiency are 
dep
e compared to 
6.2   The relevance of cellular cycle phase in gene delivery 
 
Cellula
higher in cells in the S and G2/M phases, thus, the cell c
d
endent on the cell cycle phase. The largest amount of nuclear pDNA was found in the 
G2/M phase and was smallest in the G1 phase irrespective of the polyplex-type used. 
Although the amount of transgene expression is cell cycle phase-dependent, it also depends 
on the polyplex-type. The transgene expression is strongly dependent on the cell cycle phase 
in the case of PEI but not with PLL, perhaps because of the different expression efficiencies 
but also because of the PLLs ability to bind DNA strongly, thereby preventing the release of 
the pDNA and/or other aspects of its intracellular kinetics. A similar effect of cell cycle 
phase on transgene expression has been reported by other groups (Brightwell et al. 1997; 
Brunner et al. 2000; Brisson et al.1999).  The cell cycle phase restricted also the expression 
of the integrated endogenous luciferase gene to some extent in a stable cell line, suggesting 
that this effect of cell cycle on cellular uptake and transgene expression is real. These results 
suggest that transcription and translation machinery is affected by the cell cycle phase. In our 
case this effect may be contributed by competition of transcription factors due to 
simultaneous expression of CMV-driven stable endogenous (luciferase) and transient 
exogenous (β-galactosidase) proteins in the cells. It also appears that non-specific 
pinocytosis (fluid-phase endocytosis) is also cell cycle-dependent, being least efficient 
during the G1 phase, whereas receptor-mediated is not cell cycle-dependent. Brunner et al. 
(2000) reported a constant cellular uptake in all phases by the receptor-mediated 
transferring-coupled PEI, while our results with non-specific cellular uptake revealed clear 
dependency on the cell cycle phase. In addition, our results demonstrate that the effect of cell 
cycle is not promoter specific, since all of the promoters tested exhibited similar trends in 
cell cycle dependence. However, the efficiency in terms of absolute protein expression 
depends on the promoter. The cell cycle effect is also not protein specific, because both β-
galactosidase and luciferase reporters revealed similar trends in transfection.  
 Very little is known about the compositional changes occurring in the cytoplasm during 
cell cycle and their potential impact on the intracellular kinetics of DNA. The less 
pronounced difference (PLL vs. PEI) in expression levels during the G1 phas
the substantial difference noted in the other phases may be a reflection of unfavorable 
circumstances (e.g. pH) for PEI within the cell or endosome resulting in weak transgene 
expression. Also, changes in membrane tension during the cell cycle (Raucher et al. 1999) 
may modify cellular uptake and transgene expression. The role of mitosis in nuclear uptake 
and efficient gene delivery is controversial (Zauner et al. 1999; Chan et al. 1999; Pollard et 
al. 1998). Our data indicates  that though  mitosis may  promote  nuclear uptake, its necessity  
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seems to have been overestimated. Also the study by Ludke et al. (2002) indicated that DNA 
can enter the nucleus in non-dividing cells after cytoplasmic microinjection, but at a lower 
fficiency than into the nucleus of dividing cells, and thus, nuclear membrane breakdown 
GAGs are abundant polyanions in the extracellular matrix and are present on the cell 
es and polyplexes may react with GAGs, 
ading to DNA release or relaxation (Ruponen et al. 1999), and in that way modify 
tran
nd nucleus 
dur
 
e
does not seem to be essential for penetration in to the nucleus. Although nuclear breakdown 
may assist in nuclear uptake and successful transgene expression, this nuclear reassembly 
may extrude large macromolecules from the nucleus (Swanson et al. 1987), resulting in 
lowered gene expression. Furthermore, the size of nuclear pores can change according to the 
activity of the cell, and therefore, it has been claimed that access to the nucleus might be 
better during S phase than during the G1 phase (Feldher et al. 2001). Finally, the intranuclear 
electrical potential changes during the cell cycle. The negativity increases when cells go 
through G1 phase towards the beginning of mitosis reaching the highest electrical potential 
during the G2 phase with the lowest potential occurring during mitosis (Giulian et al. 1977). 
This follows the charges of chromatin: during mitosis, when chromosomes are in a 
condensed state, the charges of the DNA are partially neutralized by positively charged 
histones, but after mitosis, DNA unravels and its negativity increases until the cells start to 
progress to mitosis again. Thus, our transfection results seem to follow the intranuclear 
potential present during the cell cycle.  
 
6.3   The relevance of GAGs in gene delivery  
. 
surface as part of the proteoglycans. Lipoplex
le
sfection. The experiments with exogenous anionic HA, the least abundant endogenous 
GAG in D407 cells, did not relax the complexes of linear or dendritic PLL 20 kDa at any 
N:P charge ratio, whereas CS-C, the most abundant endogenous GAG in D407 cells, could 
recover 10–15 % of  the fluorescence at charge ratios above 1:1. The sulfated CS interferes 
with positive PLL polyplexes more efficiently than HA due to its higher negative charge 
density. Despite their initially different DNA binding properties, dendritic and linear PLL 20 
kDa showed similar sensitivity to interactions with GAGs. Therefore, GAG interactions on 
the cell surface probably do not account for their different transfection activities. 
Our data on cells of D407 RPE cell line show that CS is the predominant endogenous 
GAG on the cell surface and in the growth medium, while HS, and particularly HA, are less 
abundant. Interestingly, GAGs analyzed from the culture medium, cytoplasm a
ing the cell cycle can be qualitatively very different (Fedarko et al.1986). For example, 
confluent cells (primarily in G1 phase) have a higher degree of sulfation than dividing cells; 
this being especially the case for the amounts of HS in the nuclear membrane and nucleus 
(Fedarko et al.1986). Consequently, structural differences in GAGs, together with the 
differences in the amounts of GAGs during cell cycle could have influenced the cellular 
uptake of polyplexes.  
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Taking into account the average molecular mass of one nucleotide (~325 g/mol), the size 
of pCLuc plasmid (6244 bp) and the estimation that usually a single plasmid (Golan et 
al.1999) is condensed into a single complex with PEI, we can roughly calculate that 20 
pg/cell of pDNA is equivalent to about 3 × 106 complexes/cell. The number of total sulfated 
GA
es can form polyplexes, but their transfection efficiency 
was weak and they are not applicable for gene delivery purposes. However, starch is a 
 an advantage in a gene carrier. We also studied 
odifications of the SB dendrimer, but none of the investigated polymers were more 
effi
om anionic 
pol
G chains on the surface of each cell was about 2.2–4.0×106. This implies that if the 
complexes interacted with the cell surface GAG chains at the same time, there would be 
approximately a stoichiometric ratio (0.8–1.3) between the GAG and the complex. If we take 
into account the cellular uptake results, showing clearly higher cellular polyplex uptake in 
the cells in the S and G2/M phases (>3-fold) than G1 phase cells (~30 % PEI 25 kDa, ~ 5 % 
PLL 200 kDa), it is unlikely that such small quantitative differences in GAG concentrations 
on the cell surface would have such dramatic impacts on PEI- or PLL-mediated cellular 
uptake and transgene expression.  
 
6.4 New efficient gene carriers? 
 
We found that starch derivativ
biodegradable polymer, which is
m
cient transfection agent than PEI 25 kDa. We observed that PEGylation decreased the 
size of SB dendrimers, which is also supported by our observation with PEG-PLL: 
PEGylation sterically stabilizes PLL polyplexes and permits the determination of the size of 
individual complexes. We also found that inclusion of a carboxylic moiety as a functional 
group was not benefical in gene delivery with the polymers PDMAEG and PDMAEMA. 
Complexes with a pyridine moiety, however, displayed some efficiency of transfection into 
D407 cell line cells, but did not reach the level of PEI 25 kDa in our study. Thus, none of the 
carriers examined in this study presented an alternative for PEI carrier in gene delivery. 
However, these results do not mean that these polymeric carriers may not be useful in other 
cell lines (than D407) or perhaps novel modifications may solve these problems. 
Liposomal coating can protect polyplexes from extracellular polyplex-binding proteins 
when they are administerd i.v., but they can also be beneficial in mechanistic studies of gene 
delivery (i.e. intracellular routing and examining the importance of GAGs in gene delivery). 
We found that coating can rather well protect PEI polyplexes from attack fr
ymers, but the precipitation of the coated-complexes prevented further studies. 
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7        CONCLUSIONS 
.  The  physicochemical  properties  of  PLLs  can  differ  to  some  extent  but  this  does  not 
necessarily  have  a  major  impact  on  the  biological  activity  –  cellular  uptake  and 
cy.  
 
.  PEGylation sterically stabilizes the complexes in buffer, but does not protect them from 
G1  phase  than  in  cells  in  the  S  and  G2/M 
phases. Only a part of the nuclear pDNA is available for transcription.  
5. 
n  the  cell  cycle 
phase  in  PEI‐mediated  gene  delivery:  transgene  expression  is  at  its  highest  in  the  S 
 
6.  
diated cellular uptake of 
A  is more efficient  than PLL‐mediated uptake only  in cells  in  the G1 phase, and 
   
7.  
 
8.  Amylose‐rich  starch  derivatives  are  able  to  condense  pDNA  efficiently,  while  pure 
t promote transgene expression.  
 
 
1
transfection efficien
 
2.  The dendritic polymer structure is less favourable than the linear structure in terms of 
cellular uptake and transfection efficiency of PLL polyplexes.  
3
sulfated  GAG.  In  addition,  PEGylation  does  not  hamper  the  cellular  uptake  or  the 
transfection efficiency of PLL polyplexes.  
 
4.  The cellular uptake and the efficiency of transcription machinery are dependent on the 
cell cycle phase. The cellular uptake, nuclear accumulation of pDNA, and transfection 
efficiency  are  less  efficient  in  cells  in  the 
 
Efficiency  of  the  transgene  expression  depends  on  the  promoter:  the  viral  promoters 
SV40,  CMV  and  tk  are  more  efficient  in  terms  of  absolute  protein  expression  than 
human  origin  PDE‐β.  The  efficiency  of  the  promoter  is  dependent  o
phase cells but almost negligible in the cells in the G1 phase.    
 
Polyplex‐type  modifies  the  effect  of  cellular  uptake,  intracellular  distribution  and 
transfection efficiency during  the cell cycle, but  the main difference  in PLL‐ and PEI‐
mediated transfections is detected at the nuclear level. PEI‐me
pDN
the  levels of  transgene expression and expression efficiency are higher with PEI  than 
PLL polyplexes in all phases of the cell cycle.   
Cell surface GAGs do not solely account for the differential pDNA uptake or transgene 
expression during the cell cycle.  
amylopectin does not possess this property. Amylose‐rich starch/pDNA polyplexes can 
be taken up by cells but they do no
 
9.  Carboxylic acid as a functional group in polymeric PDMAEG and PDMAEMA carriers 
does not seem to confer any benefits in terms of transfection efficiency.  
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